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The conjunctiva plays an important role in maintaining the optical clarity of the cornea by 
providing a lubricated, tear film-producing surface. Disorders of the ocular surface, such 
as Stevens Johnson syndrome, ocular cicatricial pemphigoid and chemical burns, result in 
injury to the cornea and conjunctiva. This results in significant morbidity from impaired 
wound healing, scarring, vascularization and eventual visual loss. Limbal stem cell 
transplantation successfully restores the corneal surface in these eyes, but fails to address 
the conjunctival damage that is present.
  
 
Various disorders involve the conjunctiva, such as pterygia and conjunctival tumors. 
Treatment of these disorders involves surgical excision of the diseased area resulting in 
an epithelial defect that, if left to heal by secondary intention would lead to significant 
scarring and fibrosis. The use of a free autograft results in iatrogenic injury to the harvest 
site and may further complicate the management of patients with extensive or bilateral 
ocular surface disorders, or patients with glaucoma requiring filtration surgery.  
 
 
The use of bioengineered conjunctival equivalents represents a novel approach to replace 
diseased conjunctiva with healthy epithelium, without causing iatrogenic injury from 
harvesting large autografts. It is particularly useful in situations where the normal 
conjunctiva is deficient either from disease or scarring. Current methods used to 
bioengineer tissue-equivalents utilize serum-containing culture media and murine 3T3 
feeder cells, with the attendant disadvantages of the variability of serum that varies from 




As such, I have developed a serum-free culture system for the in vitro propagation of 
conjunctival epithelial cells, which remained proliferative in vivo and maintained the 
normal in vivo characteristics of the original tissue. The use of serum-free media is 
significantly advantageous, because it eliminates the need for serum and murine feeder 
cells, and reduces the risk of zoonotic infection. I further describe the use of a multistep 
serum-free culture system in developing a conjunctival epithelial equivalent with 
improved proliferative and structural properties, which are crucial for enhancing graft-
take and regeneration of the conjunctival surface following clinical transplantation.   
 
I report the successful use of these cultivated conjunctival epithelial equivalents for the 
treatment of patients with ocular surface disorders that required conjunctival excision and 
replacement. These findings have important clinical implications and are important for 
the development of a safe and effective bioengineered tissue-equivalent for clinical use, 
such as in the regeneration of the ocular surface in conditions where the normal 
conjunctiva is damaged or deficient. 
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The ocular surface is comprised of two phenotypically distinct epithelia, the conjunctiva 
and the cornea, which are each highly specialized.  The conjunctiva, which consists of a 
stratified epithelium interspersed with numerous goblet cells, plays in important role in 
maintaining the integrity and stability of the ocular surface.  The conjunctiva is involved 
in tear film production and maintenance, in nourishing the ocular surface through its 
generous vasculature, and in immunologic and physical protection to the globe.  Ocular 
surface diseases such as Stevens-Johnson syndrome, chemical and thermal burns, ocular 
surface tumours and immunologic conditions can severely damage the conjunctiva, 
thereby compromising its vital supportive role and resulting in catastrophic visual loss.  
The conjunctiva may also be damaged iatrogenically through ophthalmic surgical 
procedures that require manipulation and removal of conjunctiva, such as in pterygium 
surgery, glaucoma surgery and oculoplastic procedures.   
 
At present attention has been almost exclusively focused on the corneal surface, with all 
new ocular surface transplantation procedures involving limbal or corneal epithelial cell 
replacement.  Current techniques of transplanting the limbal stem cell population in 
ocular surface diseases have limited success, as this serves to replace only the corneal 
epithelium.  The lack of the supportive function of the conjunctiva often contributes to 
the failure.  To date, few, if any, investigators have focused on the conjunctiva, in the 
form of conjunctival and fornix reconstruction and restoration of physiological functions.   
 
There is a perceived need to develop methods to replace normal conjunctiva.  The use of 
bioengineered ocular surface replacement tissue would avoid the problems associated 
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with current techniques, and if successful, would revolutionise the treatment of ocular 
surface diseases.  This would minimise damage to the donor eye, as only a small biopsy 
of ocular surface stem cells will be carried out.  Ex vivo expansion of the harvested stem 
cells and cultivation upon a substrate results in a composite graft tissue that would be 
transplanted back to the eye to replace damaged corneal or conjunctival epithelium. To 
focus on functional and morphological reconstruction of the conjunctiva would be an 
important approach to intervene at an earlier stage in ocular surface disease progression, 
in an attempt to try and prevent secondary corneal epithelial damage.   
 
This novel approach in developing a reconstructed conjunctival equivalent may be used 
to replace diseased or deficient conjunctiva. If successful, this autologous conjunctival 
substrate may be utilized in a host of ocular procedures affecting the conjunctiva, which 
include glaucoma, pterygium surgery, and oculoplastic reconstructive procedures. There 
is therefore considerable clinical potential.  This may subsequently be extended to the 
cultivation of limbal stem cells for corneal epithelium replacement, which would 












CHAPTER 2  
 
OCULAR SURFACE STEM CELL 






The ocular surface is a complex biological continuum responsible for the maintenance of 
corneal clarity, elaboration of a stable tear film for clear vision, as well as protection of 
the eye against microbial and mechanical insults. The ocular surface epithelium 
comprises corneal, limbal and conjunctival epithelia, of which the conjunctiva extends 
from the corneal limbus up to the mucocutaneous junction at the lid margin, and is 
divided anatomically into bulbar, forniceal and palpebral regions. The precorneal tear 
film, neural innervation and the protective blink reflex help sustain an environment 
favourable for the ocular surface epithelium.   
 
OCULAR SURFACE STEM CELLS 
 
Adult corneal and conjunctival stem cells represent a small, quiescent subpopulation of 
epithelial cells of the ocular surface. The limbus is a 1.5 to 2mm wide area that straddles 
the cornea and bulbar conjunctiva. Corneal epithelial stem cells reside in the basal region 
of the limbus, and are involved in the renewal and regeneration of the corneal epithelium 
(Thoft et al., 1989; Tseng, 1989, 1996; Dua, 1995; Dua et al., 2000). Following injury, 
these limbal basal stem cells are stimulated to divide and undergo differentiation to form 
transient amplifying cells (TACs) (Figs. 2.1 and 2.2). Subsequent cell divisions result in 
non-dividing post-mitotic cells (PMCs), which then terminally differentiate and migrate 
towards the central cornea and superficially, taking on the final corneal phenotype as 
terminal differentiated cells (TDCs). Their presence allows continued replacement and 
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regeneration of tissues following injury, thereby maintaining a steady-state population of 
healthy cells.  
 
The ocular surface is an ideal region to study epithelial stem cell biology, because of the 
unique compartmentalization of the corneal epithelial stem cells within the limbal region, 
which provides us with a valuable opportunity to study the behaviour of stem cells and 
transient amplifying cells, how they respond to various growth stimuli, and the 
mechanisms that modulate their growth and differentiation (Thoft et al., 1989; Tseng, 
1989, 1996; Dua, 1995; Dua et al., 2000).  
 
By comparison, conjunctival stem cell biology has been much less investigated compared 
to corneal stem cells. Conjunctival and corneal epithelial cells have been shown to belong 
to 2 separate distinct lineages (Wei et al., 1996). Unlike corneal epithelium, conjunctival 
epithelium consists of both non-goblet epithelial cells as well as mucin-secreting goblet 
cells. Wei et al showed that both these populations of cells arose from a common bipotent 
progenitor cell (Wei et al., 1993, 1997). The conjunctival forniceal region appears to be 
the site that is rich in in conjunctival stem cells, although stem cells are also likely to be 




Figure 2.1. Schematic diagram showing hierarchy of stem cell (SC), transient amplifying cell 
(TAC1, TAC2 , and TAC3 ), post-mitotic cell (PMC), and terminally differentiated cell (TDC). 
Upon division, the stem cell (shaded square) gives rise to regularly cycling TA cells, which have 
shorter cell cycle times, and undergo rapid cell division. A self-renewal process, possibly by 
asymmetric division, maintains the stem cell population. 
 
Figure 2.2. A schematic diagram of the ocular surface epithelium showing the proliferation and 
transit of cells arising from the stem cells located at the limbus. The limbal basal stem cells 
divide to form transient amplifying cells which migrate centrally and superficially to form 





IDENTIFICATION OF STEM CELLS 
 
To date, several putative stem cell markers have been proposed, although no single 
molecular marker that is specific for stem cells has been identified. This has significantly 
limited our capacity to study the characteristics and behavior of these cells. Taking 
advantage of the slow-cycling characteristic of stem cells, an indirect method of labeling 
stem cells was developed (Cotsarelis et al., 1989; Lehrer et al., 1998; Lavker et al., 1998). 
Continuous administration of tritiated thymidine (
3
H-TdR) for a prolonged period labels 
all dividing cells. Slow cycling cells that remain labeled for a prolonged period are 
termed “label-retaining cells” and are believed to represent stem cells (Cotsarelis et al., 
1989; Lehrer et al., 1998; Lavker et al., 1998). Cotsarelis et al  confirmed the presence of 
a small subpopulation of slow-cycling label-retaining limbal basal stem cells that had a 
significant reserve capacity and proliferative response to wounding (Cotsarelis et al., 
1989).   
 
Another characteristic of stem cells is their capacity to remain highly proliferative in vitro 
(Barrandon and Green, 1987; Lavker et al., 1991; Pellegrini et al., 1999). Cells that have 
the highest proliferative capacity (holoclones - with less than 5% of colonies being 
terminal) are considered to be stem cells (Barrandon and Green, 1987; Pellegrini et al., 
1999). Pelligrini et al showed by clonal analysis that nuclear p63 was abundantly 
expressed by epidermal and limbal holoclones, but were undetectable in paraclones, 
suggesting that p63 might be a marker of keratinocyte stem cells (Pellegrini et al., 1999). 
Other markers that have been suggested include alpha-enolase expression, as well as the 
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presence of high levels of α6-integrin and low to undetectable expression of the 




 cells (Zieske et al., 1992; Tani et al., 
2000). Connexin 43 was also found to be absent in the limbal basal cells, as was gap-
junction mediated cell-to-cell communication, as detected by the lack of cell-to-cell tracer 
(Lucifer yellow) transfer (Matic et al., 1997). This absence of intercellular 
communication may be an inherent feature of stem cells, reflecting the need for these 
cells to maintain the uniqueness of its own intracellular environment. 
 
TREATMENT OF OCULAR SURFACE STEM CELL DEFICIENCY 
  
With the widespread acceptance of the limbus as the site of corneal stem cells, limbal 
stem cell transplantation was introduced as a definitive means of replacing the corneal 
stem cell population in the diseased eye (Dua, 1995; Tseng, 1996; Kenyon and Tseng, 
1989; Coster et al., 1995; Tsubota, 1997, Tsubota et al., 1999). Limbal autograft 
transplantation, first described in detail by Kenyon and Tseng, is essentially limited to 
unilateral cases or bilateral cases with localized limbal deficiency, where sufficient 
residual healthy limbal tissue is available for harvesting (Kenyon and Tseng, 1989). In 
these cases, the procedure involves lamellar removal of 2 four-clock hour limbal 
segments (usually superior and inferior) from the healthy donor eye, and transplantation 
of these segments to the limbal deficient eye, after a complete superficial keratectomy 
and conjunctival peritomy to remove unhealthy diseased surface epithelium. For patients 
with bilateral diffuse disease, the use of allogeneic limbal grafts is required. In the case of 
cadaveric donors the entire 360 degree annulus of limbus can be transplanted, either as an 
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intact annular ring, or in several contiguous segments.  Limbal allografts may also be 
obtained from HLA-matched living-related donors, to reduce the risk of immunologic 
rejection (Dua et al., 1999).   
 
Limbal transplantation may be combined with penetrating keratoplasty either performed 
at the same setting, or as a staged procedure. In cases of severe ocular surface disease, 
there is often associated conjunctival and lid pathology, which may require adjunctive 
surgical procedures to augment the reconstruction of the ocular surface, such as lamellar 
keratoplasty, conjunctival transplantation, forniceal reconstruction with release of 
symblepharon, and correction of cicatrizing lid disease (Coster et al., 1995; Tsubota, 
1997, Tsubota et al., 1999; Dua et al., 1999; Tan, 1999).  
 
More recently, human amniotic membrane has been shown to facilitate wound healing by 
promoting epithelial cell migration and adhesion, by possessing growth factors that 
encourage healing, and by its anti-inflammatory properties (Tseng et al., 1998; Meller et 
al., 2000; Solomon et al., 2002).  As such, amniotic membrane transplantation has been 
used in the treatment of persistent epithelial defects, limbal stem cell deficiency and 
reconstruction of the ocular surface (Tseng et al., 1998; Meller et al., 2000; Solomon et 
al., 2002).
 
    
 




Limbal autograft surgery overcomes the problem of immunologic rejection but may only 
be used for patients with unilateral limbal stem cell deficiency. Because fairly large 
segments are required, this places the donor eye at risk and may eventually result in 
surgically-induced limbal stem cell deficiency in the donor eye. The use of autologous 
cultivated limbal stem cell transplantation has been employed to overcome this problem 
(Lindberg et al., 1993; Pellegrini et al., 1997; Schwab et al., 2000; Tsai et al., 2000; 
Koizumi et al., 2001).  
 
The ex vivo expansion of limbal epithelial stem cells in vitro, followed by transplantation, 
provides a new modality for the treatment of limbal stem cell deficiency (Lindberg et al., 
1993; Pellegrini et al., 1997; Schwab et al., 2000; Tsai et al., 2000; Koizumi et al., 2001). 
For this procedure, only a small limbal biopsy (approximately 2mm
2
) is required, which 
minimizes potential damage to the healthy contralateral donor eye. This is then cultivated 
on various substrates, such as human amniotic membranes or fibrin-based substrates 
which results in a composite graft tissue that is then transplanted onto the diseased eyes. 
Although the long term results and safety of this procedure have yet to be determined, 
reasonable success of up to 1 year of follow-up has been achieved (Lindberg et al., 1993; 




Previous investigators have demonstrated that these amniotic membrane cultures 
preferentially preserved and expanded limbal epithelial stem cells that retained their in 
vivo properties of being slow cycling, label retaining, and undifferentiated (Meller et al., 
2002).
 
This novel technique proves to be a promising therapeutic option for patients with 
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unilateral or bilateral ocular surface disease, as only small amounts of tissue are required 
for the expansion of cells, which minimizes iatrogenic injury to the donor eye. The use of 
these bioengineered corneal surface tissues with a complement of stem cells may thus 
provide a safer and more effective treatment option.   
 
ROLE OF CONJUNCTIVA IN MAINTAINING THE INTEGRITY OF THE 
OCULAR SURFACE 
  
The conjunctiva plays an important role in maintaining the optical clarity of the cornea by 
providing a lubricated, tear film-producing surface. Disorders of the ocular surface, such 
as Stevens-Johnson syndrome, ocular cicatricial pemphigoid and chemical burns, result in 
injury to the corneal epithelial stem cells at the limbus, as well as the conjunctiva. This 
results in significant morbidity from impaired wound healing, scarring, vascularization 
and eventual visual loss (Tseng, 1989, 1996; Dua, 1995). Limbal stem cell transplantation 
successfully restores the corneal surface in these eyes, but fails to address the 
conjunctival damage that is present.
  
 
Damage to the conjunctiva may also arise from various diseases, such as pterygia and 
conjunctival tumors. Treatment of these disorders involves surgical excision of the 
diseased area resulting in an epithelial defect that, if left alone, undergoes secondary 
intention wound healing with epithelial migration from adjacent conjunctiva.  
Accompanying subconjunctival fibrosis and cicatrisation may result in symblepharon 
formation, conjunctival fornix shortening and cicatricial eyelid deformation. To prevent 
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this, normal conjunctiva obtained as a free autograft is often harvested from the superior 
bulbar conjunctiva of the same or fellow eye and sutured over the defect.  This may be 
accompanied by significant fibrosis and scarring at the donor site (Vrabec et al., 1993), 
and further complicate the management of patients with extensive or bilateral ocular 
surface disorders, or patients with glaucoma, where glaucoma filtration surgery over the 





























BIOENGINEERED CONJUNCTIVAL TISSUE-EQUIVALENTS 
 
The use of bioengineered conjunctival equivalents represents a novel approach to replace 
the conjunctival epithelium, without causing iatrogenic injury from harvesting large 
autografts. It is particularly useful in situations where the normal conjunctiva is deficient 
either from disease or scarring. Bioengineered corneal and limbal tissue-equivalents that 
have been described for the treatment of ocular surface disorders utilize serum-containing 
culture media that is often combined with 3T3 feeder cells (Pellegrini et al., 1997; Tsai et 
al., 2000; Koizumi et al., 2001; Shimazaki et al., 2002). This, however, is associated with 
disadvantages because of the variability of serum that varies from batch to batch, and the 
risk of transmission of zoonotic infection.  The use of serum-free media would be 
significantly advantageous, because it eliminates the need for serum and murine feeder 
cells, and reduces the risk of zoonotic infection. Its use in the ex vivo expansion of 






The main aims of my study were:: 
1. To develop a serum-free culture system for the ex vivo expansion of conjunctival 
epithelial cels propagation 
2. To develop a transplantable cultivated conjunctival epithelial equivalent in serum-free 
media 
3. To evaluate the use of cultivated autologous conjunctival tissue-equivalents for the 
treatment of ocular surface disorders.   
 
This novel treatment modality may be particularly useful for extensive or bilateral 
conjunctival disorders. The use of these conjunctival equivalents would be advantageous 
as it removes the need for harvesting conjunctival autografts and causing iatrogenic 















SERIAL PROPAGATION OF HUMAN 
CONJUNCTIVAL EPITHELIAL CELLS 






The conjunctival epithelium is complex, consisting of bulbar, forniceal and palpebral 
zones, which are morphologically distinct. Furthermore, within each zone the epithelium 
contains two cell types: stratified squamous epithelial cells and goblet cells. The stratified 
squamous epithelial cells make up the outermost barrier, while the goblet cells elaborate 
mucins, which are glycoproteins that comprise a major component of the tear film (Wei 
et al., 1993). The mechanisms that regulate the stratified squamous epithelial cell and 
goblet cell proliferation and differentiation are largely unknown. Examination of these 
events in vivo is complicated by the multitude of epithelial and mesenchymal factors that 
contribute to the complex ocular environment. Therefore cell culture is one of the best 
means for examination of the role of individual growth factors and mitogens in these 
processes.  
 
Single-cell clonal growth and serial propagation of keratinocytes was first described by 
Rheinwald and Green, using serum-containing medium in combination with lethally-
irradiated 3T3 feeder layers (Rheinwald and Green, 1975; Sun and Green, 1977; 
Rheinwald 1980).
 
This method of cultivation remains the most widely used method for 
the propagation of epithelial cells (Lindberg et al., 1993; Tsai et al., 1994; Wei et al, 
1997; Meller and Tseng, 1999; Pellegrini et al., 1999).
 
Much of the previous work carried 
out on the cultivation of ocular surface epithelial cells (i.e. cornea, limbal and 
conjunctival epithelial cells) have utilized serum-containing media and 3T3 feeder layers 
(Tsai and Tseng, 1988; Chen et al., 1994; Wei, Sun and Lavker, 1996; Diebold et al., 
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1997; Cho et al., 1999; Meller and Tseng, 1999; Koizumi et al., 2000).  A major problem 
with this approach is that serum consists of a complex mixture of cytokines, hormones, 
peptide growth factors, and undefined components, that may vary from batch to batch. In 
addition, the presence of serum and feeder layers in the culture system may confound the 
effects of individual cytokines, and precludes the analysis of the role of individual factors 
in modulating cellular proliferation and differentiation. For this reason, investigators have 
experimented with different serum-free formulations for the cultivation of epithelial cells. 
Cultivation of keratinocytes without a feeder layer at low calcium concentrations was 
achieved with the use of MCDB-153 or MCDB-151 medium containing trace elements, 
ethanolamine, phosphoethanolamine, triodothryronine, hydrocortisone, hEGF, and 
bovine pituitary extract (Maciag et al., 1981; Walthall and Ham, 1982; Boyce and Ham, 




Much of the previous work on the cultivation of conjunctival epithelial cells has been 
carried out in animal models (Tsai and Tseng, 1988; Chen et al., 1994; Wei, Sun and 
Lavker, 1996; Cho et al., 1999; Meller and Tseng, 1999).
 
There have been few reports 
describing the cultivation and propagation of human conjunctival epithelial cells 
(Pellegrini et al., 1999; Tsai, Ho and Chen, 1994; Diebold et al., 1997, Risse Marsh et al., 
2002). Lavker and colleagues previously reported the successful cultivation of human 
conjunctival epithelial cells using serum-free media, and demonstrated that small biopsies 
of human conjunctiva could be initiated as explants and subsequently subcultured, while 
retaining the normal phenotypic characteristics of the cells (Risse Marsh et al., 2002). I 
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attempted to further improve the culture conditions, by reducing the concentration of 
bovine pituitary extract, which was the only variable component, and by modifying the 
calcium concentration. To our knowledge, cultivation of human conjunctival epithelial 
cells at clonal densities using serum-free, chemically-defined media has not been reported.  
 
I analyzed the proliferative capacity of human conjunctival epithelial cells cultivated in 
serum-free media, and compared it with conventional culture conditions using serum and 
3T3 feeder cells. I also investigated whether this serum-free culture system supported the 
growth of the two cell types present in the conjunctival epithelium (squamous epithelial 




Human conjunctival biopsies were obtained from prospective surgical patients after 
obtaining proper informed consent and approval. All experimental procedures performed 
conformed to the Association for Research in Vision and Ophthalmology Statement for 
the Use of Animals in Ophthalmic and Vision Research, and the guidelines of the 
Declaration of Helsinki in Biomedical Research Involving Human Subjects. Approval 
was obtained from the Singapore National Eye Center and Singapore Eye Research 




Isolation and cultivation of human conjunctival epithelial cells  
Under an operating microscope, biopsies of superior bulbar conjunctival tissue 10-14 mm 
from the limbus, measuring approximately 2mm x 2mm in size, were obtained from 
healthy donors undergoing pterygium surgery. The conjunctival epithelium was carefully 
dissected free from the underlying stroma. The conjunctival tissue was placed in DMEM, 
cut into 0.5 to 1mm pieces, and placed onto 35mm dishes. Culture media was added, in 
an amount just sufficient to submerge the explants. Care was taken to prevent the 
explants from floating. After the initial outgrowth of cells from the explants, more media 
was added to completely submerge the explants. All cultures were incubated at 37
o
C, 
under 5%CO2 and 95% air, with media change carried out every 2-3 days. Cultures were 
monitored with a Zeiss Axiovert (Oberkochen, Germany) inverted phase-contrast 
microscope. 
 
The conjunctival epithelial cells were cultivated under the following three different 
culture conditions: (i) serum-free media alone; (ii) serum-free media with a 3T3 feeder 
layer; and (iii) serum-containing media with a 3T3 feeder layer 
 
The serum-free media used consisted of Keratinocyte Growth Medium (KGM) 
supplemented with 10ng/ml hEGF, 5µg/ml insulin, 0.5µg/ml hydrocortisone, 30µg/ml 
bovine pituitary extract, 50µg/ml Gentamicin, and 50ng/ml Amphotericin B. The calcium 
concentration of the media was 0.15mM. On the day of initiation of the culture, 2.5% 
FBS was added, and the calcium concentration was increased to 0.9mM with calcium 
  
22 
chloride solution. From the second day onwards, the calcium concentration was 
maintained at 0.15mM and serum was completely excluded from the culture system.  
 
The serum-containing media consisted of a 3:1 mixture of DMEM-Ham’s/F12 nutrient 
mixture, supplemented with 10% FBS, 5µg/ml insulin, 0.5µg/ml hydrocortisone, 
8.4ng/ml cholera toxin, 24µg/ml Adenine, 100IU/ml penicillin, and 100µg/ml 
streptomycin.  
 
Preparation of 3T3 feeder layers. Confluent 3T3 feeder layers were treated with 4µg/ml 
mitomycin-C for 2 hours at 37
o
C under 5%CO2 and 95% air, trypsinized, and plated as a 






The 3T3 feeder layers were used 
one day after plating.  
 
Upon reaching 80% confluence, the epithelial cells were subcultured.  Enzymatic 
disaggregation was carried out using 0.125% trypsin/ 0.02% EDTA for a period of 10 
minutes. Cultures that were carried out in the presence of feeder layers were pretreated 
with 0.02% EDTA for 5 minutes to remove the feeder cells. The single-cell suspensions 




.   
 
For the purpose of characterization of the cultured conjunctival epithelial cells, cells from 
passage 3 onwards were grown to confluence. In order to promote differentiation and 
stratification, the calcium level was increased to 1.2mM for 4 days. Immunostaining of 




Quantitation of growth and proliferative capacity 
Area of cellular outgrowth from primary explant culture. The extent of outgrowth of the 
conjunctival epithelial cells from each explant cultivated under the 3 different conditions 
was monitored. After 12 days of incubation, cultures were fixed in 4% paraformaldehyde 
and stained with Rhodamine B. The area occupied by each explant and the area of 
cellular outgrowth was analyzed using a computerized image measurement software, 
Zeiss Axiovision KS300 (Oberkochen, Germany). I ensured that variances in outgrowth 
areas were not due to differences in explant sizes, because the mean areas occupied by 
the explants in serum-free media, serum-free media with 3T3 cells and serum-containing 






, respectively).  
 
Colony-forming efficiency. Upon reaching 70-80% confluence, the cultures were 
subcultured by enzymatic disaggregation with 0.125% trypsin / 0.02% EDTA, yielding 
single cell suspensions. Cells were then plated at a clonal density of 1000 cells onto 
60mm culture dishes. The entire surface of the dish was screened daily for colony 
formation with a phase-contrast microscope. A colony was defined as a group of eight or 
more contiguous cells. The number of attached cells was determined on day 2 by 
counting the entire dish. The colonies were fixed on day 10, stained with Rhodamine B, 
and counted under a dissecting microscope. Those cultures that were carried out in the 





The colony-forming efficiency was calculated as follows: 
 
    Colonies formed at end of growth period X 100% 
CFE (%)  =     Total number of viable cells seeded                                                                      
    
 
The number of population doublings, x, that could be achieved was calculated as follows: 
x  =  log2 (N/N0), where N is the total number of cells harvested at subculture, and N0 is 
the number of viable cells seeded. 
 
Immunocytochemistry and immunohistochemistry 
Conjunctival epithelial cell cultures were grown on glass cover slips and fixed with 
acetone at -20
o
C for 10 minutes. Normal bulbar conjunctival tissue that was used as a 
normal control was embedded in OCT freezing compound. Frozen sections were cut at 
5µm in thickness and fixed with acetone for 10 minutes. The cells and frozen sections 
were incubated for 1 hour with AE1 and AE3 monoclonal antibodies, and antibodies to 
K3 (AE-5 antibody), K4, K12, K19, and MUC5AC. K4 and K19 are expressed in normal 
conjunctival epithelium, while K3 (AE-5 antibody) and K12 are expressed in corneal 
epithelial cells. MUC5AC was used to detect the presence of the gel-forming mucin 
present in conjunctival goblet-cells (Argeuso et al., 2002; Shatos et al., 2003; Tei et al., 
1999; Inatomi et al., 1996).
 
Normal mouse immunoglobulin was used as a negative 
control. The cells were subsequently incubated with secondary antibody (1:200 
biotinylated horse anti-mouse immunoglobulin G for 1hour. The reaction product was 
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observed using a mouse immunoperoxidase detection kit in combination with DAB 
visualization. MUC5AC was detected by immunofluorescence by incubation with FITC-
conjugated secondary antibody (goat anti-mouse IgG). This was counterstained with 
propidium iodide at 2.5µg/ml for 15 minutes, and mounted with Vectashield mounting 
medium.   
 
RNA isolation and RT-PCR of MUC5AC 
Total RNA was isolated from cultured conjunctival epithelial cells using a guanidinium 
isothiocyanate protocol (RNaeasy; Qiagen, Santa Clarita, CA), and subjected to RNase-
free DNase I digestion, extracted twice with phenol:chloroform:isoamyl alcohol (24:24:1), 
precipitated with ethanol, dissolved in RNase-free water, and quantified 
spectrophotometrically. One microgram of total RNA was used for cDNA synthesis 
(SuperScript II reverse transcriptase; Invitrogen, Carlsbad, CA) according to the 
instructions from the manufacturer. At the end of the reaction, RNaseH was added to 
remove the RNA template.  PCR was performed with primers for human MUC5AC 
(Shatos et al., 2003). The primer sequences were as follows: MUC5AC sense primer, 5’-
TCCACCATATACCGCCACAGA-3’; and antisense primer, 5’-
TGGACCGACAGTCACTGTCAAC-3’.  The amplification reaction was performed in a 
thermal cycler (PCR Sprint; Thermo Hybaid, Ashton, UK). The conditions were: 3 
minutes at 96
o
C, followed by 30 cycles of denaturation for 45 seconds at 96
o
C, 
amplification for 1 minute at 55
o
C, and extension for 1 minute at 72
o
C.  The predicted 
length of the PCR product was 103-bp (Shatos et al., 2003). Amplified cDNA was 
analyzed by electrophoresis on a 1% agarose gel in buffer containing 89 mM Tris borate 
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(pH 8.3) and 2mM EDTA and viewed by ethidium bromide staining. Total RNA from 
forniceal conjunctival epithelium was used as a positive control.  Actin PCR was 
conducted at the same time as a system control. 
 
Statistical methods 
The independent t-test was used to compare the means of the various growth parameters 
between the various culture conditions (area of outgrowth, colony forming efficiency and 
number of population doublings). Analysis was performed using SPSS (version 9.0, 




Morphology of conjunctival epithelial cells in primary explant culture and in serial 
cultures 
Serum-free media. Human conjunctival epithelial cells cultivated in serum-free media 
began to migrate from the explants on the first day. These initial migratory cells were 
small and round, with a prominent nucleus and scanty cytoplasm. Continued migration 
and proliferation of the cells resulted in the cells becoming closely apposed to one 
another, forming an epithelial sheet with an advancing border of loosely arranged cells. 
The closely apposed cells within the mid-peripheral region of the epithelial sheet 
exhibited a cobblestone appearance (Fig. 4.1A). The cells took 9 to 12 days to reach 80% 
confluence.  After subculturing, single attached cells divided to form 4-cell colonies by 
day 2, and continued to proliferate to form 30-cell colonies by day 6. Each colony 
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consisted of a collection of small, round or ovoid cells. The cells were arranged mainly as 
a monolayer with focal areas showing 2 or more layers after 8 days. Confluent colonies 
had a cobblestone morphology (Fig. 4.1A inset). 
 
Serum-free media and 3T3 feeder cells. Conjunctival epithelial cells cultivated in serum-
free media and 3T3 feeder cells began migrating from the explants on the first day and 
formed a sheet of epithelial cells with a clearly defined advancing border by day 4. The 
small, round and ovoid cells were more closely packed than those grown in the absence 
of feeder cells (Fig. 4.1B). Areas of squamous cells were present by day 4 and the rate of 
migration diminished over subsequent days in culture. By day 5, the 3T3 feeder cells 
progressively lifted off the culture dish. The cells took 12 to 15 days to reach 80% 
confluence. Upon subculturing, cells formed loosely spaced colonies with a greater 
number of elongated cells than in serum-free media alone (Fig. 4.1B inset). The epithelial 
colonies were predominantly a monolayer of cells with little evidence of stratification.  
 
Serum-containing media with 3T3 feeder cells. The epithelial cells migrated from the 
explants by day one, and over the next few days, formed a densely populated epithelial 
sheet, with a well-defined advancing edge. Areas of stratification and differentiation were 
observed on day 5 to 6. The area of outgrowth was greater than the other 2 culture 
conditions at corresponding time intervals. The cells were the most densely packed of the 
3 culture conditions, with clearly defined refractile borders observed between the cells 
(Fig. 4.1C). The cells took 9 to 12 days to reach 80% confluence. Passaged single-cell 
suspensions formed 4 to 8-cell colonies by day 3. These colonies consisted of closely 
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apposed small, round or ovoid cells, with clearly defined circular margins adjacent to the 
surrounding feeder cells. Areas of stratification were noted by day 5. Confluent cultures 
consisted of a uniform population of densely packed ovoid and round cells (Fig. 4.1C 
inset).  
 
Growth and proliferative capacity  
Areas of outgrowth from primary explant cultures. The rate of initial outgrowth was 
similar in all 3 conditions. However, cells cultivated in serum-free media with feeder 
layers showed a decline in the rate of outgrowth by day 4. The mean areas of outgrowth 
after 12 days of culture are shown in Figure 4.2. The outgrowth area for serum-free 
media alone (n=22, 61.6+24.7mm
2
) was greater than for serum-free media and 3T3 
feeder cells (n=18, 30.3+17.6mm
2
). This difference was statistically significant (t-test, 
p=0.049). The outgrowth area for serum-containing media with 3T3 feeder cells (n=20) 
was 78.9+11.6mm
2
. It is interesting to note that the difference between serum-free media 




Colony-forming efficiency (CFE). The mean colony-forming efficiencies of conjunctival 
cells cultivated under the 3 different conditions are shown in Figure 4.3 and Table 4.1. 
Cells cultivated in serum-containing media with 3T3 feeder layers (n=16) had the highest 
colony-forming efficiency (20.4+6.7%), followed by cells in serum-free media 
(14.5+4.1%). However, this difference was not statistically significant (t-test, p=0.214). 
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There was a reduction in the colony forming efficiency of cells cultured in serum-free 
media with feeder layers (n=14), as compared to serum-free media alone (n=18, 
10.1+3.1%), although this difference was also not statistically significant (t-test, 
p=0.113).  
 
Number of population doublings. With serum-free media (n=18), epithelial cells 
underwent 24.8+4.3 population doublings before undergoing senescence (Table 4.2). Co-
culturing with feeder layers (n=14) did not enhance the proliferative capacity of these 
cells as they could only undergo 14.8+3.6 population doublings.  Serum-containing 
media with feeder layers (n=16) allowed cells to undergo 30.0+5.0 population doublings.  
The difference in the number of population doublings between serum-free media and 
serum-free media with feeder layers was statistically significant (t-test, p=0.009), while 
the difference between serum-free media and serum-containing media with feeder layers 
was not statistically significant (t-test, p=0.142).   
 
Characterization of cultured conjunctival cells  
Conjunctival cells cultivated in serum-free media demonstrated a positive 
immunoreactivity for antibodies AE1 and AE3, and antibodies to K4 and K19, but not K3 
or K12 (Figs. 4.4A-C). This was identical to the immunostaining pattern of cells 
cultivated in serum-containing media with feeder cells (Figs. 4.4E,F). In all 3 conditions, 
scattered clusters of goblet cells that expressed the MUC5AC goblet cell mucin were 
noted (Fig. 4.4D). The immunostaining pattern was consistent with that of the original 




In addition, total RNA was reverse transcribed and analyzed by PCR for the message of 
MUC5AC. The message for MUC5AC was detected as a 103-bp band in conjunctival 
epithelial cells cultured in serum-free media as well as in serum-containing media with 
3T3 feeder cells (Fig. 4.5). The integrity of RNA was confirmed by the amplification of 
actin mRNA. These results confirmed the existence of MUC5AC gene expression in cells 
under these culture conditions. 
  
31 
Figure 4.1. Phase contrast appearance of conjunctival epithelial cells cultivated initially as 
explants and subsequently subcultured as cell suspension monolayers. Serum-free media: (A) 
primary explant culture, (Inset A) monolayer culture. Serum-free media and 3T3 feeder cells: (B) 
primary explant culture, (Inset B) monolayer culture. Serum-containing media and 3T3 feeder 








   
 
Figure 4.2. Areas of epithelial cell outgrowth from primary explants on day 12 of culture, under 
the 3 culture conditions: Serum-free media (SFM, n=22), serum-free media and 3T3 feeder cells 







Figure 4.3. Colony-forming efficiency of conjunctival epithelial cells cultivated under the 3  
culture conditions. Serum-free media (SFM, n=18), serum-free media and 3T3 feeder cells 
(SFM/F, n=14) and serum-containing media and 3T3 feeder cells (SCM/F, n=16). 
 
Table 4.1. Colony-forming efficiency (CFE) of conjunctival epithelial cells cultivated under 
different culture conditions. Cells were plated at a clonal density of 1000 cells per 60 mm culture 
dish.  
  
Culture conditions No of 
samples 
Passage 2 (mean CFE+SD) Passage 3 (mean CFE+SD) 
Serum-free media alone 18 14.5 + 4.1% 12.4 + 3.5% 
Serum-free media with 
3T3 feeder layer 
14 10.1 + 3.1% 6.2 + 1.9% 
Serum-containing media 
with 3T3 feeder layer 
16 20.4 + 6.7% 15.4 + 5.6% 
 
Table 4.2. The number of serial passages and population doublings for each culture condition. 
 
Culture conditions No of 
samples 
Mean number of 
population doublings + SD 
Average no. of passages 
(range) 
Serum-free media alone 18 24.8 + 4.3 6 (4 to 8) 
Serum-free media with 
3T3 feeder layer 
14 14.8 + 3.6 4 (3 to 5) 
Serum-containing media 
with 3T3 feeder layer 




Figure 4.4. Immunocytochemistry of conjunctival epithelial cells cultivated in serum-free media 
(A-D) and serum-containing media with feeder cells (E,F). The serum-free cultured cells stained 
positively for (A) keratin 4 and (B) keratin 19.  (C) Cultured cells did not stain with the antibody 
to the cornea-specific keratin 12. (D) Immunofluorescence staining with an antibody to MUC5AC 
demonstrating a pair of MUC5AC-positive cells (indicated by arrows). Conjunctival epithelial 
cells cultivated in serum-containing media with 3T3 feeder cells also stained positively for 







Figure 4.5. Presence of MUC5AC transcripts in cultured conjunctival epithelial cells. MUC5AC 
transcripts were detected in cDNA from human forniceal conjunctiva (lane 1), conjunctival 
epithelial cells cultured in serum-containing media with 3T3 feeder cells (lane 2), and 
conjunctival epithelial cells cultured in serum-free media (lane 3). PCR was performed with 
water replacing cDNA as the negative control (lane 4). Lane M represents the molecular weight 






I demonstrated that a chemically defined serum-free culture system supports the clonal 
growth, serial propagation and differentiation of human conjunctival epithelial cells. The 
elimination of serum and feeder cells from the culture system has many advantages. It 
provides a more defined condition for future investigations on the effect that different 
cytokines have on the growth and proliferation of conjunctival epithelial cells. It also 
reduces the risk of transmission of zoonotic infection when used in the ex-vivo expansion 
of cells for clinical transplantation.  
 
The presence of serum resulted in proliferation that was accompanied by early 
stratification and the appearance of squamous epithelial cells. In comparison, the colonies 
in the serum-free cultures consisted of round and ovoid cells with less squamous change 
at corresponding time points. In terms of the various growth parameters analyzed 
(outgrowth area, colony-forming efficiency and number of population doublings), the 
serum-free culture was able to achieve comparable results to the serum plus 3T3 system, 
without the attendant disadvantages of the use of serum and animal material.  
 
Castro-Munozledo et al demonstrated clonal growth and serial transfer of rabbit corneal 
epithelial cells under serum-free culture conditions at a calcium concentration of 1.2mM, 
and replacing bovine serum with bovine serum albumin in a DMEM-Ham’s F12 (3:1) 
nutrient media (Castro-Munozledo, Valencia-Garcia and Kuri-Harcuch, 1997). They 
found that a lethally-treated 3T3-cell feeder layers was necessary to support keratinocyte 
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growth, as well as to allow the formation of well-defined colonies of stratified cells. We 
found that serum-free media alone, at a concentration of 1.2mM, resulted in early 
differentiated colonies that had a limited ability for serial propagation. The calcium 
concentration of 0.15mM was found to be more favorable in supporting the proliferation 
of these cells. We found that the combination of 3T3 feeder cells with this serum-free 
media resulted in a reduction in the proliferative capacity of these cells.  
 
Bovine pituitary extract was the only variable component present in the culture system. In 
previous reports on cultivating epidermal keratinocytes with serum-free media, bovine 
pituitary extract was found to be an essential supplement in promoting epithelial 
proliferation (Boyce and Ham, 1983; Wille et al., 1984; Maciag et al., 1981; Pillai et al., 
1988).
 
Previous studies that used serum-free formulations without bovine pituitary extract 
for corneal epithelial cells, did not demonstrate serial transfer and stratified epithelial 
organization, and growth was accompanied by abnormal differentiation with the 
formation of cornified envelopes (Kruse and Tseng, 1991, 1992). The concentration of 
pituitary extract used in our study (30µg/ml) was significantly less than what has been 
described (70-150µg/ml), while still supporting  the successful serial propagation of these  
cells, without the formation of cornified envelopes (Boyce and Ham, 1983; Wille et al., 
1984; Maciag et al., 1981; Pillai et al., 1988).  
 
In conclusion, serial cultivation of human conjunctival epithelial cells can be achieved 
under serum-free media, without the reliance on feeder cells. The resultant cultures had 
many of the normal phenotypic characteristics of the in–vivo starting epithelium. The use 
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of this culture system will be advantageous for studying the roles of various cytokines, 
growth factors, hormones, and compounds that are involved in modulating epithelial cell 
proliferation and differentiation. Knowledge of the interaction between various cytokines 
will improve our understanding of the mechanism by which the delicate balance of 


















THE IN VIVO PROLIFERATIVE 
CAPACITY OF SERUM-FREE 







Cultivation of epithelial cells in serum-free media without a feeder layer was made 
possible with the use of MCDB-153 or MCDB-151 medium containing trace elements, 
ethanolamine, phosphoethanolamine, triodothryronine, hydrocortisone, human epidermal 
growth factor (hEGF), and bovine pituitary extract (Maciag et al., 1981; Tsao et al., 1982; 
Boyce and ham, 1983; Lechner, 1984; Wille et al., 1984; Shipley and Pittelkow, 1987; 
Pillai et al., 1988; Hackworth et al., 1990; Kruse and Tseng, 1991a; 1991b; Castro-
Munozledo et al., 1997; Diebold et al., 1997).
 
The use of serum-free media has primarily 
been for the study of factors that modulate cellular proliferation and differentiation 
(Kruse and Tseng, 1991a; 1991b; Castro-Munozledo et al., 1997; Tsao et al., 1982; 
Lechner, 1984; Shipley and Pittelkow, 1987; Hackworth et al., 1990). Serum-free media 
has not been used in the ex vivo expansion of ocular surface cells for clinical 
transplantation. This may be attributed to the lack of information regarding the efficacy 
of serum-free media in supporting the serial propagation of cells compared to serum-
containing methods, as well as the uncertainty of the viability and proliferative potential 
of these cells when transplanted back to the in vivo environment.  
 
Various authors have demonstrated the use of serum-free media for the cultivation of 
human conjunctival epithelial cells (Girolamo et al., 1999; Risse Marsh et al., 2002). 
However, the ability of these cultivated cells to remain proliferative in vivo has not been 
adequately addressed. The viability of cultured cells and their ability to continue to 
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proliferate in vivo is the overriding consideration in clinical transplantation. As such, i 
chose to address these issues by studying the in vitro as well as in vivo proliferation of 
serum-free cultivated human conjunctival epithelial cells, and compare it with 
conventional culture conditions containing serum and 3T3 feeder cells.  A study of this 
nature has not been previously described, and would provide valuable insights into the 
use of serum-free media for transplantation purposes. Conjunctival epithelium was 
chosen as it is more complex than corneal or limbal epithelium, and comprises 2 
phenotypically distinctive cell types: stratified squamous epithelial cells and goblet cells 
(Wei et al., 1993,1996; Chen et al., 1994).  
 
I wanted to determine if in vitro cultivated cells retained their ability to form a stratified 
epithelium when returned to an in vivo environment. I found that serum-free cultivated 
cells exhibited an in vivo proliferative capacity and ability to form stratified epithelium 
that was equivalent to cells cultivated in serum-containing media. This has important 
clinical implications, as it is the first demonstration of the suitability of using a serum-




Human conjunctival biopsies were obtained from prospective surgical patients after 
obtaining proper informed consent and approval, according to the statutes of the 
Institutional Review Boards of the Singapore National Eye Center and the University of 
Pennsylvania. All experimental procedures performed conformed to the Association for 
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Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic 
and Vision Research, and the guidelines of the Declaration of Helsinki in Biomedical 
Research Involving Human Subjects.  
 
Isolation and cultivation of human conjunctival epithelial cells  
Under an operating microscope, conjunctival biopsies were obtained from patients 
undergoing routine surgery for nasal pterygium or cataract. A small piece of normal 
conjunctiva (1x3mm in size) was removed from the superior bulbar region, 15mm from 
the limbus, located well away from the pterygium. Previous reports have shown that the 
conjunctiva in this region is essentially normal (Chan CM et al., 2002; Shimmura et al., 
2000). Patients that had extensive pterygia or any other ocular surface disorders that may 
have involved the area of biopsy were excluded from the study. The conjunctiva was 
dissected free from the underlying tenons. Thirty-two specimens were collected from 32 
eyes of donors aged 30 to 70 years old (mean age 63.2 years). Twenty one donors were 
male and 11 were female.  
 
The conjunctival tissue was cut into 0.5 to 1mm pieces, and placed onto 35mm dishes. 
Five hundred microliters of culture media were added, which was just sufficient to 
submerge the explants. Care was taken to prevent the explants from floating. After the 
initial outgrowth of cells from the explants, more media was added to completely 
submerge the explants. All cultures were incubated at 37
o
C, under 5%CO2 and 95% air, 
with media change carried out every 2-3 days. Cultures were monitored with a Zeiss 




The conjunctival epithelial cells were cultivated under the following three culture 
conditions: (i) serum-free media alone; (ii) serum-free media with a 3T3 feeder layer; and 
(iii) serum-containing media with a 3T3 feeder layer 
 
The serum-free media used consisted of KGM with various supplements, as described in 
Chapter 3. The calcium concentration of the media was 0.15mM. On the day of initiation 
of the culture, the calcium concentration was increased to 0.9mM with calcium chloride 
solution, which was equivalent to the calcium concentration present in a conventional 1:1 
mixture of DMEM/Ham’s F12 mixture used for cultivating ocular surface epithelial cells 
(Tsai and Tseng, 1988; Tsai et al., 1994; Meller and Tseng, 1999). From the second day 
onwards, the calcium concentration was maintained at 0.15mM.  
 
The serum-containing media consisted of a 3:1 mixture of DMEM-Ham’s/F12 nutrient 
mixture, supplemented with 10% FBS, 5µg/ml insulin, 0.5µg/ml hydrocortisone, 
8.4ng/ml cholera toxin, 24µg/ml Adenine, 100IU/ml penicillin, and 100µg/ml 
streptomycin. The 3T3 feeder layers were prepared as described in Chapter 3.  
 
Upon reaching 80% confluence, the epithelial cells were subcultured.  Enzymatic 
disaggregation was carried out using 0.125% trypsin/ 0.02% EDTA for a period of 10 
minutes. Cultures that were carried out in the presence of feeder layers were pretreated 
with 0.02% EDTA for 5 minutes to remove the feeder cells. The single-cell suspensions 








For the purpose of characterization of the cultured conjunctival epithelial cells, cells from 
passage 3 onwards were grown to confluence. In order to promote differentiation, the 
calcium level was increased to 1.2mM for 4 days. Immunostaining of the cells was 
performed, as described below.  
 
Implantation of cultivated conjunctival epithelial cells into athymic mice 
Cell suspensions of epithelial cells from passages 2 to 5 of each culture condition were 
implanted into athymic mice, aged 7 to 9 weeks old. Upon reaching 80% to 90% 
confluence, the epithelial cells were detached by light trypsinization (0.125% trypsin in 
0.01% EDTA) at 37
o
C for 5 to 10 minutes, and resuspended in 0.4ml of media. Aliquots 
containing 2 x 10
6 
cells were injected subcutaneously into the flanks of athymic mice. 
The athymic mice were euthanised by asphyxiation with carbon dioxide at 6, 9 and 12 
days following implantation, to determine the time-point at which the greatest number of 
cells were present.  
 
I compared the in vivo proliferation of cells derived from the 3 culture conditions. 
Because the degree of stratification of the epithelium was fairly uniform throughout the 
entire cyst, the number of cell layers in the stratified epithelium was measured at the level 
of the greatest cyst diameter. The number of cells in each cyst was calculated as follows. 
The cell diameters of 1000 cells were measured using computerized image measurement 
software (Zeiss Axiovision KS300) and the average diameter determined. This was found 
to be 12+2µm. Four-micron sections were cut through the entire cyst and the volume was 
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calculated using the surface areas of every third section. The estimated cell number was 
derived from dividing the total epithelial cell volume by the average single cell volume. 
The ratio of the number of cells derived from serum-free media in one flank to the 
number of cells derived from serum-containing media in the contralateral flank was 
determined.   
 
Histologic and electron microscopic analysis of cysts 
Athymic mice conjunctival cysts were fixed in 4% paraformaldehyde, and embedded in 
paraffin. Four-micron sections were cut and stained with hematoxylin and eosin and 
periodic acid-Schiff (PAS). For transmission electron microscopic studies, the cysts were 
fixed in 2.0% glutaraldehyde, and 1% paraformaldehyde in 0.1M sodium cacodylate 
buffer. They were postfixed in 1% osmium tetroxide, and embedded in EPON 812. 
Sections were cut at 1µm, stained with toluidine blue and basic fuschsin, examined for 
orientation prior to obtaining ultrathin sections. Ultrathin sections were prepared for 
viewing with uranyl acetate and lead citrate, and examined under a Zeiss EM 10A 
transmission electron microscope.  
 
RESULTS 
Epithelial cysts in the athymic mice model 
Subcutaneous implantation of conjunctival epithelial cells in athymic mice resulted in an 
initial swelling at the site of injection, which decreased in size over 24 to 48 hours, due to 
the resorption of fluid. Over the next few days, the weal gradually became a small firm 
cyst, which progressively increased in size to reach a maximum diameter of 5 to 8 mm by 
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day 4 to 6. The cysts remained fairly constant up to day 9; after which, they began to 
shrink in size as a result of involutional change. These single-cell suspensions of 
conjunctival epithelial cells formed well-circumscribed cysts lined by a stratified 
epithelium.  
 
The greatest number of cells was found in cysts 9 days post-implantation (Table 5.1). As 
such, assessment of the in vivo proliferation of cultured cells was carried out in 9-days 
old cysts. Cells cultured in serum-free media formed cysts that were lined by a stratified 





. The basal cells were cuboidal, with progressive flattening of the cells 
towards the surface. Cysts derived from cells cultured in serum-containing media with 





(Fig. 5.1C). The number of cells in cysts derived from serum-free 




, which was less than that derived from 
serum-free media alone.  
 
PAS staining showed the presence of many red-staining granules in the superficial layers 
of cells (Fig. 5.1D). Few PAS-positive cells resembling goblet cells were present (Fig. 
5.1D inset). Electron microscopic examination revealed the presence of a multilayered 
epithelium with prominent basal cells that were attached to the underlying basal lamina 
through focal hemidesmosomes (Figs. 5.2A and inset). Microvillus extensions were 
present over the apical surfaces of superficial cells (Fig. 5.2B).  
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Figure 5.1. Light microscopic examination of athymic mice conjunctival cysts. (A) Low and (B) high power 
views of serum-free cultured cells, demonstrating cysts lined by stratified squamous epithelium 
(hematoxylin and eosin staining). The basal cells were cuboidal, with progressive flattening of the cells 
towards the surface. (C) Cysts derived from cells cultured in serum-containing media with 3T3 feeder cells 
were similar in morphology to those derived from serum-free media. (D) PAS staining of cysts derived from 
serum-free media showed the presence of red granules in the superficial layers of cells, with few PAS-
positive cells resembling goblet cells (indicated by arrow in inset). (A) Bar = 250µm. (B-D) Bar = 125µm.  
 
Figure 5.2. (A) Transmission electron microscopy of the athymic mice conjunctival cyst showing the 
presence of a multilayered epithelium with prominent basal cells, that were attached to the underlying 
basal lamina through focal hemidesmosomes (arrows) (Inset A). (B) Microvillus extensions were present 





Table 5.1. The number of cells in athymic mice conjunctival cysts derived from the 3 culture 
conditions, at 6, 9, and 12 days post-implantation. 
 
 Mean number of cells in cysts ( + standard deviation) 
Culture conditions 6 days 
post-implantation 
9 days  
post-implantation 
12 days  
post-implantation 
Serum-free media, n=8 0.81x106+0.32x106 1.29x106 +0.46x106 0.90x106+0.41x106 
Serum-free media with 
3T3 feeder layer, n=8 
0.72x106+0.27x106 0.93x106 +0.49x106 0.65x106+0.37x106 
Serum-containing 










Current methods of analyzing the efficacy of culture methods focus primarily on their in 
vitro ability to support the serial propagation of cells. However, the in vitro culture 
system is an artificial environment that does not entirely mimic the in vivo situation.    
The critical issue in cultivating cells for clinical transplantation is the ability of these cells 
to continue to proliferate in vivo, so as to replenish and regenerate the tissue in question. 
Therefore, when analyzing the use of a culture system for the ex vivo expansion of cells 
for transplantation purposes, it is the ability of cultured cells to remain proliferative in 
vivo that is of paramount importance. However, little has been done in this regard to 
quantify their in vivo proliferative response.  
 
I showed that a chemically defined serum-free culture system supported the clonal 
growth and serial propagation of human conjunctival epithelial cells in vitro. When these 
cells were returned to the in vivo environment, they exhibited an equivalent growth 
response and degree of stratification as cells cultivated in conventional serum-containing 
media with 3T3 feeder cells. I demonstrated that cells cultivated in serum-free media 
retained the normal in vivo keratin profile, with positive expression of K4 and K19, and 
negative staining with the corneal-specific keratin, K12. This provides the first 
demonstration that serum-free media may be an effective alternative to conventional 
serum-containing methods for the cultivation of epithelial cells. With bioengineered 
tissue equivalents showing great promise as a new modality for treating ocular surface 




Serum-free cultivated cells retained their innate ability to form a stratified epithelium 
when returned to the in vivo environment, as demonstrated by the aggregation and 
organization of injected cells to form cysts that were lined by stratified squamous 
epithelium. Cysts derived from cells cultured in serum-free media and serum-containing 
media with feeder cells were similar in terms of morphology as well as degree of 
stratification. The number of cells present in the cysts derived from serum-free cultures 
and those derived from serum-containing media and 3T3 cultures were almost identical, 
demonstrating that the elimination of serum from the culture process did not compromise 
the in vivo growth response of these conjunctival epithelial cells. Because the in vivo 
proliferation of cells derived from serum-free cultures was comparable to those from 
serum and 3T3 cultures, this supports its use in the ex vivo expansion of epithelial cells 
and the development of ocular surface equivalents for clinical transplantation, without the 
attendant disadvantages associated with the use of bovine serum and animal feeder cells. 
 
Previous reports confirm the presence of a bipotent conjunctival precursor cell that is able 
to give rise to both goblet cells and nongoblet cells (Pellegrini et al., 1999; Wei et al., 
1996, 1997). Cultivation of goblet cells in vitro has been difficult to achieve. Risse Marsh 
et al previously demonstrated the cultivation of conjunctival epithelial cells with serum-
free media, but were unable to show the presence of any goblet cells (Risse et al., 2002). 
Both Pellegrini et al and Shatos et al showed that human conjunctival goblet cells could 
be cultured in vitro, but these studies required the use of serum-containing media 
(Pellegrini et al., 1999; Shatos et al., 2003).
 
In our serum-free culture system, I was able 
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to demonstrate the presence of scattered clusters of putative goblet cells that stained 
positively for MUC5AC goblet cell mucin. These results were verified by the detection of 
MUC5AC mRNA by RT-PCR within these cells cultured in serum-free media. This was 
similar to the results obtained with the use of serum-containing media and 3T3 feeder 
cells. Conjunctival epithelial cells cultured in serum-free media were therefore able to 
retain the normal in vivo characteristics of the tissue of origin.  
 
In conclusion, cells cultivated in serum-free media were equally proliferative in vivo, as 
compared to cells cultivated in conventional serum-containing cultures with feeder cells. 
These findings suggest that serum-free cultures may be an effective alternative to serum-
containing cultures for the propagation of conjunctival epithelial cells. This is particularly 
important in situations where the elimination of animal serum and tissue is advantageous, 
such as in the study of various factors involved in modulating cell proliferation and 
differentiation, as well as in the area of bioengineering for clinical transplantation, where 
the use of a serum-free culture system is an important step towards reducing the risk of 















THE DEVELOPMENT OF A 
TRANSPLANTABLE SERUM-FREE 






Previous studies on ocular surface transplantation with bioengineered tissue-equivalents 
have focused exclusively on corneal and limbal epithelial cell replacement (Pellegrini et 
al., 1997; Koizumi et al., 2000; Schwab, Reyes and Isseroff, 2000; Tsai, Li and Chen, 
2000; Koizumi et al., 2001). Less emphasis has been placed on replacing healthy 
conjunctiva. The conjunctiva plays an important role in supporting the normal milieu of 
the ocular surface and ensuring continued clarity and survival of the corneal epithelium 
and stroma. I chose to focus on conjunctival tissue for several reasons. Firstly, the 
important supportive role that the conjunctiva plays has often been overlooked. 
Regeneration of the conjunctiva in ocular surface disorders is essential in ensuring a 
healthy ocular surface environment. Secondly, conjunctival epithelium, which is 
comprised of 2 cell types (stratified squamous epithelial cells and goblet cells), is a more 
complex structure than corneal or limbal epithelium, which each comprises of epithelial 
cells alone (Wei et al., 1993; Pellegrini et al., 1997; Wei et al., 1997).  
 
Many investigators describe the use of serum-containing media without a 3T3 feeder 
layer for the development of corneal and limbal tissue-constructs (Schwab et al., 2000; 
Tsai et al., 2000; Grueterich and Tseng, 2002; Meller, Pires and Tseng, 2002), as well as 
for conjunctival epithelial cell expansion on various substrates (Tsai and Tseng, 1988; 
Niiya et al., 1997; Meller and Tseng, 1999; Meller et al., 2002). The elimination of a 
feeder cell layer from the culture system has not been adequately assessed for its 
efficiency in supporting the serial propagation of epithelial cells.  Previous reports 
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describing the use of serum-free media have similarly not assessed its relative efficacy 
compared to existing culture methods (Diebold et al., 1997; Risse et al., 2002). The use of 
serum-free media in the development of ocular surface tissue-equivalents has not been 
previously described.  I addressed these issues in our study and compared the use of 
serum-free media and conventional serum-containing media for the ex vivo expansion of 
conjunctival epithelial cells.  
 
I describe the use of a serum-free culture system and show that it is more effective than 
the conventional serum-containing media in supporting the propagation of conjunctival 
epithelial cells. I further demonstrate the development of a serum-free derived 
transplantable human conjunctival epithelial sheet, which may be important clinically for 




Human conjunctival biopsies were obtained from prospective surgical patients after 
obtaining proper informed consent and approval, according to the statutes of the 
Institutional Review Board of the Singapore National Eye Center. All experimental 
procedures performed conformed to the Association for Research in Vision and 
Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research, 
and the guidelines of the Declaration of Helsinki in Biomedical Research Involving 




Isolation and cultivation of human conjunctival epithelial cells  
Conjunctival biopsies were obtained from patients undergoing routine surgery for nasal 
pterygium or cataract. A small piece of normal conjunctiva (1x3mm in size) was removed 
from the superior bulbar region, 10-15mm from the limbus. Patients with extensive 
pterygia or with any other ocular surface disorders that might involve the area of biopsy 
were excluded from the study. Twenty-eight specimens were collected from donors aged 
24 to 63 years old (mean age 57.3 years).  
 
Preparation of human amniotic membrane (HAM) 
Human placentas were obtained from mothers who had undergone cesarean sections. The 
membranes were washed with phosphate-buffered saline (PBS) to remove the blood 
clots. The HAM was peeled away from the chorion and flattened onto a sterilized 
nitrocellulose filter paper. The HAM was then stored in 50% DMEM, 50% glycerol at –
80
o
C. In preparation for its use, the HAM was thawed, rinsed with PBS, and incubated 
with Dispase II 1.2 U/ml for 2 hours. This was followed by gentle scraping to remove any 
remaining amniotic epithelial cells.  The HAM was trimmed in size to a 3cm x 3cm 
square, and placed basement–membrane side up on a nitrocellulose support in a 35mm 
culture dish.  
 
Ex vivo expansion of conjunctival epithelial cells on HAM 
The conjunctival tissue was cut into 0.5 to 1mm pieces, inoculated onto the basement-
membrane side of the HAM, and 500µl of media were added to submerge the explants. 
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Ex vivo expansion of conjunctival epithelial cells was carried out with serum-free and 
serum-containing media. The serum-free media used consisted of KGM, with 
supplements, as described in Chapter 3. The calcium concentration of the media was 
0.15mM. On the day of initiation of the culture, the calcium concentration was increased 
to 0.9mM with calcium chloride solution, which was equivalent to the calcium 
concentration present in a conventional 1:1 mixture of DMEM-Ham’s F12 media. From 
the second day onwards, the calcium concentration was maintained at 0.15mM.  
 
The cells were incubated at 37
o
C, under 5%CO2 and 95% air, with media change carried 
out every 2 to 3 days.  Cultures were monitored under a Zeiss Axiovert inverted phase-
contrast microscope. When the initial outgrowth of cells from the explants occurred, the 
volume of media was increased to fully immerse the explants.  
 
When a confluent layer of cells was obtained on the HAM after 8 to 10 days, the cultures 
were divided into 3 groups: 
  
Submerged cultures. The calcium concentration of the serum-free media was increased to 
1.2mM for 4 days to promote differentiation and stratification.   
 
Air-lifted cultures. The calcium concentration of the serum-free media was increased to 
1.2mM and air-lifted for 6 and 12 days, so as to allow further stratification and 
differentiation of the epithelial cells. Air-lifting was performed by lowering the level of 
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media to the level of the membrane. Close monitoring of the fluid level was carried out 
twice daily to ensure the desired medium level was maintained. 
 
The effect of serum-supplementation was evaluated using serum-containing media that 
consisted of a 1:1 mixture of DMEM and Ham’s F12 media, supplemented with 10% 
FBS, 5µg/ml insulin, 0.5µg/ml hydrocortisone, 8.4ng/ml cholera toxin, 24µg/ml Adenine, 
50µg/ml Gentamicin, and 50ng/ml Amphotericin B.  
 
Cells in each culture condition were subcultured, to determine their long-term 
proliferative capacity. Subculturing was performed by enzymatic disaggregation with 







Quantitation of growth and proliferative capacity of cells 
The following proliferation assays were used to assess the proliferative capacity of cells 
cultured on HAM under the various culture conditions:  
 
BrdU ELISA Cell Proliferation Assay (Proliferation Index). The BrdU uptake by dividing 
cells was measured by an ELISA cell proliferation assay. I analyzed the proliferative 
capacity of primary cultures of conjunctival epithelial cells on HAM at the end of the 
culture periods for each condition. Subcultured cells were evaluated on day 6 of passage. 
Cultured cells were incubated with 10µM BrdU labeling solution for 2 hours at 37oC, 
followed by washing with 250µl of PBS containing 10% serum per well. They were fixed 
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with 70% ethanol in hydrochloric acid for 30min at –20
o
C, and incubated with 100µl of 
monoclonal antibody against BrdU for 30min, followed by 100µl of peroxidase substrate 
per well. The BrdU absorbance in each well was measured directly using a 
spectrophotometric microplate reader (Tecan spectrophotometer, Grodig, Austria) at a 
test wavelength of 450nm and a reference wavelength of 490nm. This gave us a measure 
of the degree of cell proliferation, which we termed as the proliferation index. Each 
sample was cultured in quadruplicate. Plain DMEM was used as a negative control.  
 
Colony-forming efficiency. Subcultured cells were plated at a clonal density of 1000 cells 
onto 60mm culture dishes. A colony was defined as a group of eight or more contiguous 
cells. The number of attached cells was determined on day 2 by counting the entire dish. 
The colonies were fixed on day 10, stained with Rhodamine B, and counted under a 
dissecting microscope.  
 
The colony-forming efficiency was defined as follows: 
    
Colony-forming efficiency (%) = Colonies formed at end of growth period    x 100% 
         Total number of viable cells seeded                                                                     
 
The number of cell generations, x, that could be achieved before senescence was 
calculated as follows: x = log2 (N/N0), where N is the total number of cells harvested at 




Morphology of conjunctival epithelial equivalents 
Histological analysis was performed by fixing the tissue-equivalents in 4% 
paraformaldehyde, and embedding in paraffin. Four-micron sections were cut and stained 
with hematoxylin and eosin. For transmission electron microscopic studies, the tissue-
equivalents were fixed in 2.0% glutaraldehyde, and 1% paraformaldehyde in 0.1M 
sodium cacodylate buffer. They were postfixed in 1% osmium tetroxide, and embedded 
in EPON 812. Ultrathin sections were prepared for viewing with uranyl acetate and lead 
citrate, and examined under a Zeiss EM 10A transmission electron microscope.  
 
Assay of differentiation-related markers 
Tissues were embedded in OCT freezing compound and 4µm thick sections were cut.  
The tissue was fixed with -20
o
C acetone for 10 minutes, followed by incubation for 1 
hour with monoclonal antibodies to keratin 4, keratin 19, keratin 3 (AE-5 antibody) and 
MUC5AC.  Normal mouse immunologlobulin and pancytokeratin (AE-1 and AE-3) were 
used as the negative and positive controls respectively. The cells were subsequently 
incubated with secondary antibody (1:200 biotinylated horse anti-mouse immunoglobulin 
G) for 1hour, detected with the mouse immunoperoxidase detection kit, and stained with 
DAB substrate. MUC5AC was detected by immunofluorescence by incubation with 
FITC-conjugated secondary antibody (goat anti-mouse IgG), followed by mounting with 







Human conjunctival epithelial cells cultivated in serum-free media began to migrate from 
the explants on the first day. These initial migratory cells were small and round, with a 
prominent nucleus and scanty cytoplasm. Continued migration and proliferation of the 
cells resulted in an epithelial sheet that became more densely populated and had a 
cobblestone morphology (Fig. 6.1A and inset). This confluent sheet of epithelial cells 
covered the 3 x 3 cm
2
 area of HAM after 8 days in culture. Increasing the calcium 
concentration resulted in the epithelial sheet becoming more densely populated, and more 
stratified, with cells becoming more elongated in appearance. Air-lifting for 6 and 12 
days resulted in a greater number of elongated cells.  
 
Epithelial cells cultivated in serum-supplemented media migrated from the explants by 
day one, forming an epithelial sheet. The cells were more elongated and squamous in 
appearance than serum-cultures at corresponding time-intervals (Fig. 6.1B and inset). 
Air-lifting for 6 and 12 days resulted in further stratification and an increase in the 
number of large, elongated and squamous cells.  
 
Morphology of conjunctival epithelial equivalents 
The conjunctival epithelial sheets in serum-free cultures were more stratified than those 




Submerged cultures. In serum-free media, the conjunctival epithelial sheet was initially 
1-2 layers in thickness on day 6. An increase in stratification and the appearance of 
columnar basal cells was noted with exposure to a calcium concentration of 1.2mM for 4 
days (Fig. 2A). Serum-supplemented cultures consisted mainly of flattened elongated 
cells (Fig. 2D).   
Air-lifted cultures (6 days). Serum-free cultures that were air-lifted demonstrated greater 
stratification, with columnar basal cells and progressive flattening towards the surface 
(Fig. 2B). Corresponding cultures in serum-supplemented media were less stratified (Fig. 
2E).  
Air-lifted cultures (12 days).  A slight increase in stratification was noted in 12-day air-
lifted cultures (Figs. 2D,F), compared to 6-day air-lifted cultures. The non-keratinized 
conjunctival epithelial cells were found to be particularly prone to desiccation, and close 
monitoring of the cultures and the level of the media was necessary to prevent excessive 
desiccation of the cells.  
 
Proliferative capacity 
For primary cultures, conjunctival cells cultivated in serum-free media had a higher 
proliferation index than cells cultivated in serum-supplemented media in the initial   
submerged period (Fig. 6.3A). Serum-supplemented cultures that were air-lifted for 6 
days demonstrated a significantly greater drop in proliferation index compared to 
corresponding serum-free cultures.  Prolonged air-lifting for 12 days resulted in a further 




For subcultured cells, submerged serum-free cultured cells (BrdU absorbance, 1.91+0.08) 
had a significantly higher proliferation index compared to submerged serum-
supplemented cultures (BrdU absorbance, 1.06+0.08) (Fig. 6.3B). Air-lifting resulted in a 
drop in proliferation index for serum-free as well as serum-supplemented cultures. In 
both submerged and air-lifted conditions, serum-free cultures had a higher proliferation 
index than serum-supplemented cultures.  
 
Cells cultured in serum-free media that remained submerged had a higher colony-forming 
efficiency (23.1+4.8%) than 6-day air-lifted cells (11.0+4.3%) and 12-day air-lifted cells 
(7.6+3.1%) (Fig. 6.3C). The colony-forming efficiencies of serum-supplemented cultures 
were lower than serum-free cultures for corresponding submerged and air-lifted culture 
conditions. The number of cell generations achieved by cells cultured in serum-free 
media (submerged, 25.6+4.5) was 2.1 times greater than that achieved in serum-
supplemented media (submerged, 12.1+3.0) (Fig. 6.3D). Air-lifted cultures underwent 
fewer cell generations than submerged cells.  
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Figure 6.1. Phase contrast appearance of human conjunctival epithelial cells cultivated on HAM. 
(A) Serum-free media on day 4, demonstrating epithelial cell migration from an explant. The 
leading edge is indicated by the arrows. (A Inset) High power view of the epithelial sheet 
demonstrating a cobblestone morphology with fairly uniform small, ovoid cells. (B and Inset) 
Serum-containing media on day 4. Migrating cells had a more elongated and squamous 
appearance, and were less uniform in size. Bar = 500µm. 
 
 
Figure 6.2. Light microscopic appearance of conjunctival epithelial equivalents cultivated in (A-
C) serum-free media and (D-F) serum-containing media. (A) Submerged culture on day 12 
(following 6 days of exposure to a 1.2mM calcium concentration). The epithelial sheet consisted 
of 2-4 layers of cells, with the appearance of columnar basal cells. (B) Air-lifted culture (6 days). 
Note the increase in stratification, with cuboidal basal cells and progressive flattening towards 
the surface. (C) Air-lifted culture (12 days).  (D) Submerged culture in serum-containing media 
on day 12. The epithelial sheet consisted of 1-3 layers of cells. (E) Air-lifted culture (6 days). An 
increase in stratification was noted. (F) Air-lifted culture (12 days). There was no significant 
increase in stratification compared to the 6-day air-lifted culture. Stratification of the epithelial 
sheet was more pronounced in serum-free cultures compared to serum-containing cultures at 
corresponding time intervals. The HAM is indicated by the area within the double-headed arrow. 




Figure 6.3. Proliferation assays of conjunctival epithelial cells cultivated in serum-free and 
serum-containing culture conditions. (A) BrdU ELISA cell proliferation assay of primary 
conjunctival cultures on day 6. The bars represent the BrdU absorbance in each culture 
condition. (B) BrdU proliferation assay of subcultured conjunctival cells on day 6. There was 
greater incorporation of BrdU in cells cultivated in serum-free media compared to serum-
containing media. Submerged cells had a higher proliferation index than air-lifted cells. (C) 
Colony-forming efficiency (CFE) of subcultured conjunctival cells. (D) Number of cell 
generations achieved by cells in each culture condition. Closed bars, serum-free media (SFM); 






This is the first report describing the effective use of a serum-free culture system for the 
development of a transplantable human conjunctival epithelial sheet on amniotic 
membrane. In addition, I showed that conjunctival epithelial cells cultured in a low-
calcium serum-free culture system had a greater proliferative capacity than cells 
cultivated in conventional serum-containing media, which is particularly important when 
considering propagating these cells for clinical transplantation. 
 
The multistep approach consisted of an initial one-day exposure to a calcium 
concentration of 0.9mM to promote initial cellular migration from the explant, 
maintenance in low calcium (0.15mM) serum-free media that kept the cells in a relatively 
undifferentiated, proliferative state, followed by exposure to normal levels of calcium 
(1.2mM), to promote cell stratification and formation of cell adhesion structures. The 
multistep approach that we adopted takes into account the various modulating effects by 
exogenous factors during the culture process (Boyce et al., 1983; Wille et al., 1984; Pillai 
et al., 1990), so as to improve the functional and structural characteristics of the 
transplantable tissue. I demonstrated that under both submerged and air-lifted conditions, 
conjunctival epithelial cells cultured in serum-free media had a greater proliferative 
capacity than cells cultivated in serum-containing media, without the attendant 




Tsai et al. (1994) showed that epithelial cultures on collagen matrices that were air-lifted 
were 3 to 4-cell layers thick, as compared to submerged cultures that were 1 to 2-cell 
layers thick. Similar results were noted by Meller and Tseng (1999), who kept cultures 
air-lifted for up to 4 weeks. This author similarly found that air-lifting resulted in greater 
stratification of the epithelium, compared to submerged cultures. However the difference 
was often not significant, and very close monitoring of cultures was necessary to ensure 
an optimal liquid level was maintained throughout the day. Despite rigorous monitoring, 
up to 30% of air-lifted cultures showed areas of cell degeneration and demise due to 
desiccation, which is not unexpected for non-keratinized mucosal epithelial cells. As it 
was not possible to ensure an identical media level in all parts of the amniotic membrane 
for the entire duration of air-lifting, the results of air-lifting were therefore less 
predictable.   
 
In summary, serum-free media was found to be more effective in supporting the in vitro 
conjunctival epithelial cell proliferation, compared to conventional serum-containing 
media.  Using this media, I developed a human conjunctival equivalent, with conjunctival 






















Most studies on tissue-equivalents have focused on the ability to reconstitute a tissue-
equivalent that bears the structural and functional characteristics of the tissue of origin 
(Schwab et al., 2000; Tsai et al., 2000; Grueterich and Tseng, 2002; Meller, Pires and 
Tseng, 2002; Tsai and Tseng, 1988; Niiya et al., 1997; Meller and Tseng, 1999; Meller et 
al., 2002). This has been achieved by differentiating cells in culture by modifying the 
culture conditions and air-lifting. However, terminally differentiated cells have a limited 
long-term proliferative capacity, resulting in a lower regenerative potential following 
transplantation. In addition, the use of epithelial tissue-constructs for ocular surface 
transplantation requires that cells are sufficiently attached to the underlying substrate, so 
as to prevent them from being sloughed off by direct mechanical or shearing forces, 
during or following surgical transplantation. A delicate balance is therefore necessary to 
preserve the proliferative potential of transplanted cells, while at the same time ensuring 
that transplanted cells have the necessary functional characteristics of the tissue organ. 
The ideal tissue-construct is one where transplanted cells possess a long-term 
regenerative capability for cellular renewal and replacement of the tissue. 
 
The in vivo proliferative capacity of cells in bioengineered tissue-equivalents is of 
paramount importance when used in clinical transplantation. As such, I addressed these 
issues by studying the in vivo proliferation of a serum-free ex vivo expanded conjunctival 
epithelial equivalent bearing the structural and functional characteristics of normal 
conjunctiva. This is the first study that focuses on the proliferative and functional 
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characteristics of the tissue-equivalent, for the purposes of improving graft-take and 
preserving the regenerative potential of transplanted cells. These findings have important 
clinical implications and provide valuable insights into the development of bioengineered 




Ex vivo expansion of conjunctival epithelial cells on HAM 
Human conjunctival epithelial cells were cultivated on HAM as described in Chapter 6.  
When a confluent layer of cells was obtained on the HAM after 8 to 10 days, the cultures 
were divided into 3 groups: 
  
Submerged cultures. The calcium concentration of the serum-free media was increased to 
1.2mM for 4 days to promote differentiation and stratification.   
 
Air-lifted cultures. The calcium concentration of the serum-free media was increased to 
1.2mM and air-lifted for 6 and 12 days, so as to allow further stratification and 
differentiation of the epithelial cells. Air-lifting was performed by lowering the level of 
media to the level of the membrane. Close monitoring of the fluid level was carried out 
twice daily to ensure the desired medium level was maintained. 
 
The effect of serum-supplementation was evaluated using serum-containing media as 




Xenotransplantation of conjunctival epithelial equivalents onto severe combined 
immune deficiency (SCID) mice  
 
Conjunctival epithelial equivalents that were prepared in submerged and airlifted 
conditions were xenografted onto the subcutaneous tissue of SCID mice, aged 7 to 9 
weeks old. The SCID mice were anesthetized and a three-sided rectangular incision was 
made through the dorsal skin.  The skin flap was lifted from the exposed dorsal muscle 
fascia.  The amniotic membrane with the overlying epithelial sheet was placed epithelial 
side up over the muscle fascia.  The skin flap was returned to its original anatomical 
position and the wound edges sutured with 5/0 silk sutures. The mice were euthanised by 
asphyxiation with carbon dioxide at 8 to 10 days following grafting, and the tissue 
excised for analysis.  
 
Morphology of conjunctival epithelial equivalents and assay of differentiation-
related markers 
 
Histological analysis was performed by fixing the tissue-equivalents in 4% 
paraformaldehyde, and embedding in paraffin. Four-micron sections were cut and stained 
with hematoxylin and eosin. For transmission electron microscopic studies, the tissue-
equivalents were fixed in 2.0% glutaraldehyde, and 1% paraformaldehyde in 0.1M 
sodium cacodylate buffer. They were postfixed in 1% osmium tetroxide, and embedded 
in EPON 812. Ultrathin sections were prepared for viewing with uranyl acetate and lead 
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citrate, and examined under a Zeiss EM 10A transmission electron microscope. Tissues 
were fixed in OCT, sectioned for immunohistochemistry with monoclonal antibodies to 




Xenotransplantation of conjunctival epithelial equivalents in SCID mice 
 
In the serum-free derived grafts, the greatest degree of stratification was noted in those 
cultured under submerged conditions (Fig. 7.1A). Proliferation of transplanted cells 
resulted in a significant increase in stratification of up to 8 to 12 cell layers in thickness. 
These epithelial sheets were the most organized, consisting of columnar basal cells, 
progressive flattening of the cells towards the surface, and squamous cells in the 
uppermost layers. Transplanted epithelial cells that were air-lifted for 6 and 12 days were 
less stratified and more flattened compared to submerged cultures (Figs. 7.1B,C).  
 
For grafts that were cultured in serum-supplemented media, 6-day and 12-day air-lifted 
grafts were less stratified and less organized than submerged grafts (Figs. 7.1D-F). For 
both submerged and air-lifted conditions, serum-free derived grafts underwent greater 
proliferation to form epithelial sheets that were more stratified than grafts cultured in 




Differentiation of conjunctival epithelial cells on HAM 
 
K4 and K19 were expressed in all layers of the normal conjunctival epithelium (Figs. 
7.2A,B). In the conjunctival equivalents, K4 and K19 were expressed throughout the 
epithelium in submerged cultures exposed to a normal calcium concentration for 4 days 
(Figs. 7.2C,D). A similar staining pattern was noted in air-lifted cultures (Figs. 7.2E,F). 
MUC5AC was expressed in the superficial layer of cells. K3, which is expressed in 
corneal cells, was not expressed by the conjunctival epithelial cells in all conditions. 
These findings were similar to the staining pattern of normal conjunctiva in vivo.  
 
Ultrastructural appearance of the conjunctival epithelial equivalent 
 
Transmission electron microscopy showed that on day 6 of culture, the conjunctival 
epithelial sheet was 1 to 2 cell layers in thickness (Fig. 7.3A). On day 12 of culture, 
following exposure to a normal calcium concentration for 4 days, a multilayered 
epithelial sheet was formed. Numerous microvillus extensions were present on the apical 
surfaces of the superficial cells (Fig. 7.3B), and the basal cells were columnar in 
appearance (Fig. 7.3D). Numerous intercellular interdigitations and desmosomes were 
demonstrated (Fig. 7.3E), and a fairly continuous basal lamina with hemidesmosomes 
was observed at the basal cell-HAM junction (Fig. 7.3F). These cell-substrate adhesion 
structures are important for maintaining the integrity of the epithelial sheet during and 




Figure 7.1. Light microscopic appearance of conjunctival epithelial equivalents 
xenotransplanted in SCID mice. (A-C) grafts cultured in serum-free media; (D-F) grafts cultured 
in serum-containing media. (A) Transplanted graft developed in serum-free media under 
submerged conditions. Note the highly stratified epithelial sheet, with numerous basal columnar 
cells and progressive flattening of the cells towards to surface. (B) Transplanted 6-day air-lifted 
conjunctival equivalent. (C) Transplanted 12-day air-lifted conjunctival equivalent. Note the less 
stratified epithelium with more flattened cells in 6-day and 12-day air-lifted conjunctival 
equivalents. (D) Transplanted graft developed in serum-containing media under submerged 
conditions. The degree of stratification is less the serum-free derived graft. (E) Transplanted 6-
day air-lifted conjunctival equivalent. (F) Transplanted 12-day air-lifted conjunctival equivalent. 
Note that there was little increase in the degree of stratification in transplanted 6-day and 12-day 
air-lifted grafts. The cells were also less organized the transplanted submerged graft. The HAM 






Figure 7.2. K4 and K19 expression of normal conjunctiva (A,B) and the ex-vivo expanded 
conjunctival equivalent in serum-free media (C-F). (A) K4 and (B) K19 were expressed in all cell 
layers of normal conjunctiva. (C) K4 and (D) K19 expression in cultured conjunctival epithelium 
under submerged conditions. (E) K4 and (F) K19 expression in the cultured conjunctival 
epithelium after 6-days of air-lifting. The staining pattern for K4 and K19 was similar for 
submerged and air-lifted cultures, and was consistent with the normal conjunctival keratin 













Figure 7.3. Transmission electron microscopy of conjunctival tissue-equivalents cultured in 
serum-free media. (A) Day 6 of culture, demonstrating an epithelium consisting of 1-2 layers of 
cells on HAM. (B) Day 12 of culture, demonstrating a multilayered epithelial sheet with 
numerous microvilli over the apical surface of superficial cells (indicated by arrows). (C) 
Prominent columnar basal cells were noted. (D) Intercellular interdigitations and numerous 
desmosomes (indicated by the arrows) were present. (E) A fairly well-defined basal lamina with 
numerous hemidesmosomal attachments (indicated by the arrows) was present at the basal cell-
HAM interface. Ep=Epithelial sheet, HAM=Human amniotic membrane. (A,B) Magnification 
10000x. (C) Magnification 140000x. (D) Magnification 40000x. (E) Magnification 36000x. 









Previous studies on ocular surface equivalents have relied primarily on serum-
supplemented media for the cultivation of epithelial cells. These studies focused mainly 
on the formation of a differentiated epithelial equivalent bearing the morphological 
characteristics of the original tissue (Schwab et al., 2000; Tsai et al., 2000; Grueterich 
and Tseng, 2002; Meller, Pires and Tseng, 2002; Tsai and Tseng, 1988; Niiya et al., 1997; 
Meller and Tseng, 1999; Meller et al., 2002). These terminally differentiated cells 
contribute to the structural and functional attributes of the tissue, but have a limited 
proliferative capacity in the long-term. The ability of the cultivated cells to remain 
proliferative in vivo is important for the long-term regeneration of the tissue following 
transplantation. I describe the use of a multistep serum-free culture system in developing 
a conjunctival epithelial equivalent with improved proliferative and structural 
characteristics, which are crucial for the regeneration of the conjunctival surface 
following clinical transplantation.   
 
Several authors have used long-term labeling with BrdU as an indirect method for 
determining the presence of putative progenitor cells in epithelial equivalents, by their 
label-retaining nature (Meller et al., 2002; Grueterich and Tseng, 2002). However, the in 
vivo proliferative capacity of ex vivo expanded cells in submerged and air-lifted tissue-
equivalents has not been previously assessed. The ability of serum-free derived epithelial 
equivalents to remain proliferative in vivo was confirmed in our study. There was a 
dramatic increase in the degree of stratification and proliferation of cells that were 
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originally cultured under submerged conditions. These cells proliferated more rapidly 
than air-lifted cultures and formed a stratified epithelium that was better organized into a 
basal columnar population of cells with progressive flattening of cells towards the surface. 
Air-lifted cultures that were transplanted did not undergo a significant increase in 
stratification, suggesting that prolonged incubation in vitro may be counter-productive, 
resulting in cells that were more differentiated and less proliferative. Xenografted tissue-
equivalents demonstrated a greater degree of stratification compared to in vitro tissue-
equivalents, which suggested that the in vivo environment provided a more conducive 
environment for cell growth and differentiation. As such, when considering the ex vivo 
expansion of conjunctival cells for transplantation, an earlier return to the in vivo 
environment, rather than prolonged in vitro incubation, may prove beneficial in 
preserving a greater proportion of proliferative cells at the time of transplantation.   
 
The use of tissue-equivalents in ocular transplantation requires that cells are sufficiently 
attached to the underlying substrate, to prevent them from being sloughed off during or 
following surgery, and from blinking or saccadic movements of the eye. Previous studies 
have shown that air-lifting was necessary to promote the formation of a better-developed, 
continuous basal lamella, with a higher density of hemidesmosomes, while submerged 
cultures only exhibited a rudimentary, discontinuous basement membrane structure (Tsai 
and Tseng, 1988; Tsai et al., 1994; Meller and Tseng, 1999).
 
However, air-lifting of 
cultures also results in the terminal differentiation of cells, which would be 
disadvantageous for transplantation, as these cells would have a limited regenerative 
capacity. An ideal culture system for the ex vivo expansion of epithelial cells for 
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transplantation is one that preserves the relatively undifferentiated, proliferative state of 
cells, while also ensuring the formation of cell-substrate adhesion structures that are vital 
to preventing cell loss during and following transplantation.  By altering the calcium 
concentration of the culture medium in our multistep approach, thereby making use of the 
growth modulating effect of this exogenous factor, submerged cultures elaborated a 
continuous basement membrane with numerous hemidesmosomes, as well as numerous 
intercellular desmosomes. In addition, the conjunctival epithelial equivalent expressed 
the differentiation-related markers that are consistent with that of normal conjunctiva.  
 
In summary, I describe the development of a conjunctival epithelial equivalent, using a 
multistep serum-free culture system to enhance cell proliferation, differentiation and 
attachment for clinical transplantation and tissue regeneration. These findings have  
important clinical implications and are important for the development of a safe and 
effective bioengineered tissue-equivalent for clinical use, such as in the regeneration of 














THE USE OF HUMAN SERUM FOR THE 







In the development of tissue-equivalents, the ideal culture condition is one that is safe 
from disease transmission, and being able support both the clonal growth as well as the 
serial propagation of cells. The elimination of bovine serum or animal feeder cells in the 
development of bioengineered tissue-equivalents for clinical transplantation would be 
significantly advantageous, because of the reduced risk of disease transmission (e.g. 
Bovine spongioform encephalitis and xenograft rejection). In addition, the ability of 
serum-free culture systems to promote cellular proliferation is of paramount importance 
in ensuring continued tissue regeneration following transplantation.  
 
I wanted to investigate if human serum could be used as an alternative to animal serum in 
the culture system, so as to eliminate the use of xenobiotic material in the culture system. 
I describe the influence of serum-free and serum-supplemented media conditions on the 
clonal growth and long-term proliferative capacity of cultivated cells, with the aims of 





Harvesting of human conjunctival epithelial cells and human serum 
 
Conjunctival biopsies were obtained from patients undergoing routine surgery for nasal 
pterygium or cataract. A small piece of normal conjunctiva (1x3mm in size) was removed 
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from the superior bulbar region, 10-15mm from the limbus. Patients with extensive 
pterygia or with any other ocular surface disorders that might involve the area of biopsy 
were excluded from the study. Eighteen specimens were collected from donors aged 22 to 
63 years old (mean age 56.8 years).   
 
Human serum was collected under aseptic conditions from consenting patients with no 
medical problems (age range, 20 to 32 years old; mean age, 29.3 years). The blood was 
immediately processed by centrifugation at 2500 r.p.m. for 20 minutes to separate the 
serum from cells. The serum was then stored in sterile tubes for use.     
 
Ex vivo expansion of conjunctival epithelial cells  
 
The conjunctiva was dissected free from the underlying Tenon’s, cut into 0.5 to 1mm 
pieces, and cultivated as explants on 35mm tissue-culture dishes, and 500µl of media 
were added to submerge the explants.  Ex vivo expansion of these conjunctival epithelial 
cells was carried out with serum-free and serum-supplemented media. The serum-free 
media used consisted of Keratinocyte Growth Medium as previously described. This was 






Area of outgrowth from primary explant culture, BrdU ELISA Cell Proliferation Assay, 
colony forming efficiency, and number of cells generations were analysed as previously 
described. 
 
Development and xenotransplantation of conjunctival epithelial equivalents 
 
Conjunctival specimens were cut into 0.5 to 1mm pieces and inoculated onto the 
basement-membrane side of the HAM. Five hundred microlitres of media were added to 
partially submerge the explants. When the initial outgrowth of cells from the explants 
occurred, the volume of media was increased to fully immerse the explants. When a 
confluent layer of cells was obtained on the HAM after 8 to 10 days, the calcium 
concentration of the media was increased to 1.2mM for 4 days to promote differentiation 
and stratification.  
 
These conjunctival equivalents were then xenografted onto the subcutaneous tissue of 
SCID mice, aged 7 to 9 weeks old. The SCID mice were anesthetized and 3 dorsal skin 
incisions were made to create a 2x2cm skin flap hinged at one end. The skin flap was 
raised to expose the underlying dorsal muscle fascia.  The amniotic membrane with the 
overlying epithelial sheet was placed epithelial-side up over the muscle fascia.  The skin 
flap was returned to its original anatomical position and the wound edges sutured with 
7/0 silk sutures. Eight to ten days following grafting, the mice were euthanised by 






Morphological analysis by light and electron microscopy, as well as 




Morphology and propagation of cells cultivated in serum-free and serum-
supplemented media 
 
The morphological appearance of the cells cultivated in serum-free, FBS-supplemented 
media, and HS-supplemented media is shown in Figure 8.1. Human conjunctival 
epithelial cells cultivated in serum-free media began to migrate from the explants on the 
first day. These initial migratory cells were small and round, with a prominent nucleus 
and scanty cytoplasm. Continued migration and proliferation of the cells resulted in an 
epithelial sheet that became more densely populated, with areas of stratification. 
Following subculturing, cell colonies consisted of small, round or ovoid cells (Fig. 8.1A). 
Forty to fifty-cell colonies were formed by day 7 to 9.  
 
In both FBS and HS-supplemented media, epithelial cells migrated from the explants by 
day one, and over the next few days, formed an epithelial sheet with a well-defined 
advancing edge. The cells were more elongated and squamous in appearance than serum-
free cultures at corresponding time-intervals. Large and elongated differentiated cells 
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were observed in the epithelial sheet by days 5 and 6 for FBS, and days 4 and 5 for HS.  
Clearly defined refractile borders were present between the cells.  
 
Following subculturing, the colonies in serum-supplemented cultures consisted of 
elongated, large, differentiated cells with a low nuclear-cytoplasmic ratio (Figs. 8.1B,C). 
Cells in FBS took 9 to 11 days to form 40 to 50-cell colonies, and those in HS took 10 to 
12 days to form 40 to 50-cell colonies. These were significantly longer than the time 
taken for serum-free media.   
 
Fibroblast proliferation was noted in both FBS as well as HS supplemented media (Figs. 
8.1D,E) by passage 2 of culture. Fibroblasts continued to proliferate in each passage, 
eventually overgrowing the entire culture dish by passage 3 or 4 (Fig. 8.1F). In contrast 
serum-free cultures selectively supported the propagation of epithelial cells, with no 




FBS-supplemented media was associated with more rapid cellular outgrowth than the 
other culture conditions during the first 3 days in culture (Fig. 8.2A). After 4 days, the 
area of outgrowth was greater in serum-free cultures compared to serum-supplemented 
cultures at corresponding time intervals. On day 12, the areas of outgrowth from explants 
were 46.4+9.6mm
2 
in serum-free media, 34.8+7.7mm
2
 in FBS-supplemented media, and 
25.7+6.5 mm
2




Cells cultivated in serum-free media had a significantly higher proliferation index 
(1.41+0.21) compared to FBS-supplemented media (0.87+0.12) and HS-supplemented 
media (0.58+0.15) (Fig. 8.2B). The differences between serum-free media and serum-
supplemented media were statistically significant (t-test, p<0.05). 
 
Clonal growth and long-term proliferation 
 
Clonal cultures in serum-free media consisted of small, ovoid or round cells. Both FBS 
and HS supplemented cultures consisted of larger, elongated cells. Serum-free media had 
a higher colony-forming efficiency (17.4+5.1%) than cells cultivated in FBS-
supplemented media (7.1+1.5) and HS-supplemented media (5.1+0.9) (Fig. 8.3A).  
 
Prolonged exposure to FBS and HS supplemented media resulted in cells undergoing 
early differentiation with a limited ability for serial propagation. The number of cell 
generations achieved in these conditions was 10.3+2.1 and 7.4+1.6 respectively (Fig. 
8.3B). In contrast, cells cultivated in serum-free media remained less differentiated and 
more proliferative. These cells were able to achieve 22.6+3.4 cell generations before 
senescence.  
 
Xenotransplantation of conjunctival epithelial equivalents in SCID mice 
 
Serum-free derived conjunctival epithelial equivalents were 2-3 layers in thickness by 
day 8 of culture (Fig. 8.4A). Eight days following transplantation into SCID mice, 
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stratified conjunctival epithelial sheets 10-12 layers in thickness were formed (Fig. 8.4B). 
These serum-free derived epithelial sheets were the most organized amongst the various 
culture conditions, with columnar basal cells, progressive flattening of the cells towards 
the surface, and squamous cells in the uppermost layers.  
 
Xenografted conjunctival equivalents cultured in FBS-supplemented and HS-
supplemented media underwent less proliferation and stratification and were less 
organized compared to serum-free media cultures (Figs. 8.4C,D). Eight days post-
transplantation, the conjunctival epithelial sheets derived from FBS-supplemented media 
were 5-7 layers in thickness, while those derived from HS-supplemented media were 4-6 
layers in thickness. The majority of these cells were flattened and elongated.  
 
Conjunctival epithelial cell differentiation 
 
The pattern of differentiation-related proteins expressed in the cultured conjunctival 
epithelial-HAM grafts was consistent with that of normal human conjunctiva. The 
conjunctival epithelial cells demonstrated a positive immunoreactivity for antibodies to 
AE1/AE3, K4 and K19 throughout the epithelium. The cornea associated cytokeratin, 




Figure 8.1. Phase contrast appearance of conjunctival epithelial cell cultures. (A) Passage  2 
conjunctival epithelial cells in serum-free media 6 days after plating. Each colony consisted of a 
collection of small, round or ovoid cells. (B) FBS-supplemented culture 6 days after plating 
(passage 2). A greater proportion of large, elongated cells with a lower nuclear-cytoplasmic 
ratio was present in these colonies. (C) HS-supplemented culture 6 days after plating (passage 2). 
Colonies consisted of large, elongated cells. Fibroblast proliferation was noted in (D) FBS-
supplemented cultures (passage 3), as well as (E) HS-supplemented cultures (passage 3). (F) 
Passage 4 FBS-supplemented culture demonstrating complete fibroblast overgrowth. Ep: 






Figure 8.2. (A) Areas of outgrowth (mean+SD) from conjunctival explant cultures in serum-free 
media,  FBS-supplemented media  and HS-supplemented media (n=18). During the first 4 days, 
cellular outgrowth was similar in all 3 conditions. From the 4th day onwards, cellular outgrowth 
was more rapid in serum-free media compared to serum-supplemented media.  (B) BrdU ELISA 
cell proliferation assay of cells cultivated in serum-free and serum-supplemented media (n=16). 
The bars represent the mean values of BrdU absorbance in each culture condition. There was 








Figure 8.3. Clonal growth and long-term proliferative capacity of cultivated cells. (A) The 
colony-forming efficiency (mean+SD) of conjunctival epithelial cells cultivated in serum-free 
media was significantly higher than that of FBS-supplemented and HS-supplemented media 
(n=16).  (B) The long-term proliferative capacity of cells, as determined by the number of cell 
generations achievable, was significantly greater in serum-free media compared to serum-






Figure 8.4. Human conjunctival epithelial cells cultivated on HAM. (A) Light microscopic 
appearance of an in vitro submerged conjunctival epithelial equivalent on day 8 of culture. The 
conjunctival sheet consisted of 2 to 3 layers of cells. (B) Serum-free derived conjunctival 
epithelial equivalent 8 days following transplantation into a SCID mouse, demonstrating a 
multilayered epithelial sheet comprising 10 to 12 layers of epithelial cells, with basal columnar 
cells and progressive flattening of the cells towards the surface. (C) Conjunctival equivalent 
derived from FBS-supplemented media, 8 days post-transplantation. The conjunctival sheet 
consisted of 5 to 7 layers of flattened cells. (D) Conjunctival equivalent derived from HS-
supplemented media (8 days post-transplantation) consisted of 4 to 6 cell layers of flattened, 
elongated cells. Conjunctival epithelial sheets derived from serum-supplemented cultures were 
less stratified and organized compared to serum-free cultures. The HAM is indicated by the area 












I found that conjunctival epithelial cells cultured in a serum-free culture system 
demonstrated greater clonal growth and long-term proliferation compared to cells 
cultivated in serum-supplemented media. Conversely, serum appeared to be beneficial for 
the initial attachment and migratory response of cells; however, prolonged exposure to 
serum resulted in early terminal differentiation and decreased proliferation. Conjunctival 
epithelial equivalents developed in serum-free media were also able to undergo greater 
proliferation and stratification following transplantation.  
 
Most of the previous studies on corneal and limbal epithelial equivalents have relied 
primarily on serum-supplemented media (Pellegrini et al., 1997; Tsai et al., 2000; 
Koizumi et al., 2001; Shimazaki et al., 2002). These culture conditions were able to 
support the proliferation of corneal and limbal epithelial cells without significant 
contamination by corneal keratocytes, the main mesenchymal cell present in the corneal 
stroma. In contrast, significant conjunctival stromal fibroblast overgrowth characterized 
cultures of conjunctival epithelial cells in serum-supplemented media, suggesting a 
difference in the propensity for fibroblasts from the cornea and conjunctiva to proliferate 
under serum-supplemented conditions without feeder layers. This may be related to the 
variable nature of serum, which consists of undefined concentrations of growth factors, 
cytokines, and hormones, which may have different effects on epithelial and fibroblast 
proliferation among different tissues. The presence of fibroblast overgrowth significantly 
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limits the use of FBS-supplemented or HS-supplemented media for conjunctival 
epithelial cell propagation.  
 
The elimination of bovine material and animal feeder cells is significantly advantageous 
because of the reduced risk of disease transmission. Previous reports have described 
using bovine pituitary extract to replace FBS (Boyce and Ham, 1983; Pillair et al., 1990; 
Kruse and tseng, 1993a, 1993b; Tseng et al., 1996). However, a concern throughout 
Europe is that bovine spongioform encephalitis cannot be detected by any in vitro tests. 
As such European regulatory authorities prefer that cells cultured for clinical use avoid 
the use of bovine and other animal-derived products, so as to reduce the risk of disease 
transmission. Although the use of serum-free formulations without bovine pituitary 
extract has been reported for corneal epithelial cell cultivation, serial transfer and 
stratified epithelial organization was not demonstrated, and cell cultures underwent  
altered differentiation and developed cornified envelopes (Kruse and tseng, 1991, 1993).
 
I 
demonstrated that serial propagation of conjunctival epithelial cells could be achieved in 
serum-free media in the absence of bovine pituitary extract, whilst maintaining the 
normal differentiation of cells.  
 
I investigated the use of human serum as an alternative to fetal bovine serum, as this 
would eliminate the need for bovine material in the culture process, and raises the 
possibility of using autologous serum for cultivating cells.  Although the clonal growth 
and proliferative capacity of cells cultivated in HS-supplemented media was fairly 
comparable to that of FBS-supplemented media, both these conditions were inferior to 
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that of serum-free media in terms of the selective proliferation of conjunctival epithelial 
cells without fibroblast contamination.  Serum-free media was significantly more 
efficacious than serum-supplemented media in supporting the selective proliferation of 













OCULAR SURFACE RECONSTRUCTION 








Disorders of the ocular surface, such as Stevens-Johnson syndrome, ocular cicatricial 
pemphigoid and chemical burns, result in injury to the conjunctiva. The conjunctiva may 
also be the site of various diseases, such as pterygia and conjunctival tumors. Treatment 
of these disorders involves surgical excision of the diseased area resulting in an epithelial 
defect that, if left alone, undergoes secondary intention wound healing with epithelial 
migration from adjacent conjunctiva.  Accompanying subconjunctival fibrosis and 
cicatrisation may result in symblepharon formation, conjunctival fornix shortening and 
cicatricial eyelid deformation. To prevent this, normal conjunctiva obtained as a free 
autograft is often harvested from the superior bulbar conjunctiva of the same or fellow 
eye and sutured over the defect.  This may be accompanied by significant fibrosis and 
scarring at the donor site (Vrabec et al., 1993), and further complicate the management of 
patients with extensive or bilateral ocular surface disorders, or patients with glaucoma, 
where glaucoma filtration surgery over the superior bulbar conjunctiva is contemplated.  
 
 
The use of bioengineered conjunctival equivalents represents a novel approach to replace 
the conjunctival epithelium, without causing iatrogenic injury from harvesting large 
autografts. It is particularly useful in situations where the normal conjunctiva is deficient 
either from disease or scarring. Bioengineered corneal and limbal tissue-equivalents that 
have been described for the treatment of ocular surface disorders utilize serum-containing 
culture media that is often combined with 3T3 feeder cells (Koizumi et al., 2002; 
Pellegrini et al., 1997; tsai et al., 2000).
 
The use of serum-free media is significantly 
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advantageous, because it eliminates the need for serum and murine feeder cells, and 
reduces the risk of zoonotic infection.  
 
I investigated the development of a serum-free culture derived conjunctival epithelial 







Five patients with ocular surface disorders affecting primarily the conjunctiva were 
selected for this procedure. One patient had an extensive conjunctival nevus involving 
two-thirds of the bulbar conjunctival surface. One patient had a nasal primary pterygium 
requiring surgery. Two glaucoma patients with previous glaucoma surgery performed, 
developed persistent aqueous leakage from a conjunctival bleb defect at the 
trabeculectomy site, resulting in ocular hypotony and loss of vision. One patient had 
symptomatic bilateral superior limbic keratoconjunctivitis that was not responding to 
conventional therapy. Written informed consent was obtained for all patients. These 
patients were recruited within a pilot trial on transplantation of autologous cultivated 
conjunctiva, and the clinical trial protocol and informed consent form were approved by 
the Singapore Eye Research Institute Ethics Committee. The study conduct conformed to 
scientific principles embodied in the World Medical Association Declaration of Helsinki, 




Demographic data, preoperative examination, patient symptomatology, surgical 
procedure, postoperative outcome, and complications were recorded on an itemized data 
collection form. Postoperatively, these patients were closely monitored with serial slit-
lamp examinations to assess epithelial and graft integrity, the degree of inflammation, the 
severity of scarring and the presence of complications. Fluorescein staining was used to 
access the integrity of the epithelial sheet. Main outcome measures maintenance of 
conjunctival epithelialization, integrity of the graft, resolution of the disease, recurrence, 
and presence of complications. All patients were followed up for a minimum of 6 months, 
with documented photographs of the preoperative and postoperative appearance.  
Ex vivo expansion of conjunctival epithelial cells on HAM  
 
Two weeks prior to the definitive surgical procedure, a superior forniceal conjunctival 
biopsy from the same eye, measuring 1mm x 2mm in size, was performed under topical 
anesthesia.  In the patient with the extensive nevus, due to the large size of conjunctiva to 
be removed, 2 biopsy specimens were removed and cultured.  The conjunctival tissue 
was cut into 0.5mm pieces, and inoculated onto the basement-membrane side of the 
HAM. Ex vivo expansion of these conjunctival epithelial cells was carried out in serum-
free media consisting of Keratinocyte Growth Medium, as described previously. When 
the initial outgrowth of cells from the explants occurred, the volume of media was 
increased to fully immerse the explants. The calcium concentration of the media was 
0.15mM. When a confluent epithelial sheet was attained, the calcium concentration was 




Ocular surface transplantation  
 
All patients were anesthetized with a retrobulbar block. A 7/0 vicryl traction suture was 
placed over the superior cornea 1mm from the limbus to aid in the mobilization of the eye 
for adequate surgical exposure. The area of abnormal or diseased conjunctiva was 
excised. The cultivated conjunctival epithelium on HAM was cut in size to match the 
edge of the surgical defect. The conjunctival equivalent was placed epithelial side-up 
over the surgical defect and sutured in place with interrupted 10/0 vicryl sutures. A 
second acellular sheet of HAM was placed basement-membrane side down as a 
temporary protective patch over the entire graft and sutured in place. Postoperatively, 
topical tobradex (tobramycin 0.3%, and dexamethasone 0.1%; Alcon, Fort Worth, Texas, 
USA) eyedrops were given every 3 hours for 1 week, then four times daily for 3 weeks to 
1 month following surgery. On the third postoperative day, the protective amniotic sheet 
was removed with forceps. 
 
Histological analysis of the cultured conjunctival epithelial sheet on HAM 
 
During surgery, a residual representative segment of the cultured conjunctival 
epithelium-HAM composite was retained, fixed in 4% paraformaldehyde and embedded 






Ex-vivo expansion of conjunctival epithelial cells on HAM 
 
Initial outgrowth of epithelial cells from the explants occurred by day 2. The cells were 
round or ovoid in appearance, with a healthy cobblestone morphology (Fig. 9.1A). The 
sheet of cells became progressive more densely populated by the 5
th
 day with areas that 
were multilayered. The stratified epithelial sheet of epithelial cells was confluent over the 
30mm x 30mm HAM substrate by 12 to 14 days in culture.  Histological examination of 
the conjunctival epithelial tissue-construct confirmed the presence of a stratified 
squamous epithelial sheet, consisting of 4-5 layers of cells (Fig. 9.1B).  
 
Ocular surface transplantation 
 
The demographic data of the subjects are summarized in Table 1. There were 4 males and 
3 females. The mean age was 44.3 years (range, 10 to 73 years). Five left eyes and 2 right 
eyes underwent the procedure. 
 
Complete epithelialization was confirmed by the absence of fluorescein staining within 
72 hours following surgery. None of the grafts sloughed off. In all cases, conjunctival 
inflammation was remarkably mild. There was no case of late epithelial breakdown. 
 
Resolution of the disease occurred in all patients. This included normalization of the 
intraocular pressures in both patients with ocular hypotony from persistent leaking blebs. 
In the patients that underwent pterygium surgery, none of the diseases recurred at the last 
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1-year follow-up visit. No significant subconjunctival scarring was noted. There were no 
cases of symblepheron formation, adjacent eyelid cicatrisation or distortion, or ocular 
motility restriction.  
 
The mean postoperative follow-up was 11.6 months (range, 6 to 18 months), and the 
ocular surface of the eyes with surviving transplanted epithelia remained stable and 
healthy. One eye developed mild conjunctival infection secondary to chronic blepheritis. 
The conjunctival infection resolved after 1 week of antibiotic eyedrops. No significant 




Case 1: Extensive conjunctival nevus.  
 
A 10-year-old girl presented with an extensive congenital conjunctival nevus involving 
the nasal, temporal and inferior bulbar conjunctiva (Figs. 9.2A, B). Because of the 
increasing size and bulk, ocular irritation, and cosmetic blemish, the patient underwent 
wide nevus excision with ocular surface reconstruction. The entire conjunctival nevus 
was excised in toto and the large conjunctival defect was repaired with two sheets of 
autologous cultivated conjunctiva (Fig. 9.2C). Three days following surgery, a fully 
epithelialized ocular surface was noted. There was remarkably little postoperative 
inflammation despite the extensive surgery performed. The postoperative recovery was 
uneventful and uncomplicated. An excellent cosmetic result was achieved with no 
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significant scarring or symblepharon formation. Histology confirmed the diagnosis of a 
compound nevus containing abundant melanin pigment. Eighteen months following 
surgery, the ocular surface remained healthy with minimal scarring, with only mild 
recurrence at the surgical margin (Fig. 9.2D).  
 
Case 2: Pterygium.  
 
A 42-year-old man presented with a nasal primary pterygium affecting his right eye for 
several years (Fig. 9.3A).  The pterygium was excised and the cultivated conjunctival 
epithelial sheet was transplanted over the surgical defect which measured approximately 
10mm vertically x 8mm horizontally. Complete epithelialization was noted within 72 
hours.  The degree of inflammation was noted to be relatively mild, as compared with 
conventional conjunctival autograft surgery, with no evidence of conjunctival or graft 
chemosis. There was no recurrence of the pterygium at the last follow-up at 1 year (Fig. 
9.3B).    
 
Case 3: Leaking trabeculectomy bleb.  
 
A 24-year-old man with bilateral juvenile-onset glaucoma, previously underwent bilateral 
trabeculectomy operations augmented with intraoperative mitomycin C. His right eye had 
previously developed a persistent leaking bleb that underwent a bleb revision. Within the 
first month postoperatively, significant scarring ensued with resultant bleb failure, 
necessitating 2 additional antiglaucoma medications for intraocular pressure control. 
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During the current presentation, the conjunctival bleb in left eye also developed a 
persistent fistula, resulting in ocular hypotony for 4 months despite atropine eyedrops and 
one attempt with autologous blood injection (Figs. 9.4A, B). In view of the previous bleb 
failure in the right eye, we elected to revise the bleb in the left eye using cultivated 
conjunctiva and HAM. Surgical excision of the scarred leaking conjunctival bleb was 
performed and a sheet of cultured conjunctival epithelium measuring was sutured in place 
over the sclerostomy drainage site. A good filtering bleb with no leakage was noted 
within 24 hours, and the intraocular pressure returned to normal levels. Throughout the 
postoperative period, the cultured conjunctival bleb remained healthy and epithelialized, 
with little scarring, no leakage, and normal intraocular pressures (Figs. 9.4C, D). 
 
Case 5: Superior limbic keratoconjunctivitis.  
 
A 54-year-old lady presented with a 2-year history of bilateral superior limbic 
keratoconjunctivitis that resulted in persistent ocular discomfort and redness. She was 
extremely symptomatic despite attempts at treatment with topical steroid, cromolyn 
sodium and cyclosporine eyedrops. Her right eye was more severely affected, with 
significant thickening and inflammation of the conjunctiva (Fig. 9.5A) and significant 
ocular surface staining of the unhealthy epithelium with Rose Bengal dye (Fig. 9.5B). 
Because conventional medical therapy failed to alleviate her symptoms, she underwent 
surgical excision of the diseased superior limbal and conjunctival tissue, followed by 
cultivated conjunctival transplantation. Postoperatively, there was excellent graft take, 
with full resolution of the disease condition.  The grafted conjunctiva remained healthy 
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and smooth, with minimal inflammation and scarring (Fig. 9.5C).  There was absence of 
Rose Bengal staining and no recurrence of the disease (Fig. 9.5D). At last follow-up, the 






Figure 9.1. Human conjunctival epithelial cells cultivated on HAM substrate. (A), 
epithelial cell outgrowth from explant culture on day 3, as observed under a phase 
contrast microscope. Arrows indicate the edge of the advancing epithelial sheet. (B), 
light microscopy demonstrating a stratified conjunctival epithelial sheet on HAM (HAM 
is indicated by the double-headed arrows). (A) Bar=500µm, (B) Bar=63µm. 
 
 
Figure 9.2. Case 1. (A, B), patient with an extensive conjunctival nevus affecting the 
nasal, temporal and inferior bulbar conjunctiva. (C), day 3 postoperative appearance, 
demonstrating complete removal of the nevus and transplantation of the cultivated 
conjunctiva-HAM graft over the surgical defect. (D) postoperative appearance at 18 
months.  
 
Figure 9.3. Case 2. (A), the preoperative external photograph showing a nasal primary 
pterygium in the right eye. (B), 1-year postoperative appearance showing a good 
cosmetic result, with minimal scarring and absence of recurrence. 
 
Figure 9.4. Case 3. (A), preoperative photograph showing a scarred leaking conjunctival 
filtering bleb following mitomycin-C trabeculectomy surgery in the left eye. (B), 
fluorescein staining demonstrating the site of active aqueous leakage, indicated by the 
arrow. (C), postoperative appearance 4 months after conjunctival bleb revision with 
cultured conjunctiva, showing the formation of a good new bleb, with minimal scarring. 
(D), the graft remained completely epithelialized, with absence of any aqueous leakage, 
as demonstrated with fluorescein staining.  
 
Figure 9.5. Case 5. (A), superior limbic keratoconjunctivitis in the right eye as 
demonstrated by the thickened, inflamed superior bulbar conjunctival and limbal tissue. 
(B), significant Rose Bengal staining of the unhealthy epithelium was evident. (C), 1-
month postoperative appearance, showing a healthy smooth conjunctival surface with 
minimal inflammation, thickening or scarring of the conjunctiva, and complete absence 



























Surgical removal of large areas of conjunctiva results in subconjunctival scarring and 
fibrosis, which may be complicated by granuloma formation, cicatricial fornix shortening, 
symblepharon formation, and ocular motility restriction. I describe the safe and effective 
use of cultivated autologous conjunctival epithelial cell transplantation for various ocular 
surface disorders, where conventional surgery involving the harvesting of autografts of 
flaps may have resulted in iatrogenic injury and scarring. This treatment modality may 
have important clinical applications, such as in conjunctival diseases requiring surgical 
excision and replacement with normal conjunctiva.   
 
The use of a transplantable cultivated conjunctival epithelial sheet for clinical 
transplantation has only been described in 2 previous reports (Scuderi et al., 2002; 
Sangwan et al., 2003). The elimination of bovine serum and murine feeder cells from the 
culture system has the advantage that it reduces the risk of transmission of zoonotic 
infection and xenograft rejection during clinical transplantation.  
 
HAM has been used in various ocular surface diseases (Meller et al., 2000; Honavar et al., 
2000), as well as in conjunctival wound closure and reconstruction, such as in pterygium 
surgery (Prabhasawat et al., 1997; Solomon et al., 2001),
 
leaking filtering blebs (Budenz 
et al., 2000), and fornix reconstruction (Solomon et al., 2003; Tseng et al., 1997). It has 
been shown to have antifibrotic and anti-inflammatory properties, as well as the ability to 
promote epithelial cell migration, differentiation and adhesion (Hao et al., 2000; 
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Shimmura et al., 2001). However, epithelial closure from the adjacent conjunctiva still 
needs to occur, which may take several weeks to complete (Prabhasawat et al., 1997; 
Solomon et al., 2001). This healing by secondary intention is associated with ocular 
surface inflammation, a longer postoperative recovery, and the possibility of membrane 
melting and secondary infection. Transplantation of autologous cultivated conjunctival 
epithelium results in almost immediate re-epithelialization of the ocular surface, thereby 
permitting a rapid return of the protective and supportive function provided by the 
conjunctiva. The faster wound healing would help reduce the severity of ocular surface 
inflammation and scarring. This is particularly advantageous for the treatment of diseases 
that require wide field excision of the conjunctiva or for bilateral diseases, as the use of a 
conjunctival autograft may be limited by either the lack of remaining healthy tissue in the 
same or fellow eye.  
 
Conjunctival preservation is particularly important for glaucoma patients, as conjunctival 
scarring is detrimental to subsequent glaucoma surgery success. This modality of 
treatment may therefore be useful in glaucoma drainage bleb reconstruction, such as in 
cases of failing or leaking trabeculectomy blebs which have been surgically manipulated 
without success (Schnyder et al., 2002; Budenz et al., 1999). Persistent leaking bleb 
fistulas have a significantly higher risk of blebitis and devastating endophthalmitis. 
Conventional bleb revision involving the advancement, rotation, or autografting, is 
accompanied by an exaggerated subconjunctival fibroblastic response and failure of 
intraocular pressure control. Transplantation of denuded amniotic membranes for these 
leaking glaucoma blebs, showed that only 73% of cases were completely epithelialized at 
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1 month (Budenz et al., 2000).
 
The early epithelialization of the blebs and the resolution 
of the disease in our study patients suggest the usefulness of conjunctival epithelial cell-
HAM transplantation in the treatment of this potentially blinding condition. 
 
The benefits of transplantation of autologous conjunctival epithelial equivalents include 
the ability to immediately resurface the globe and achieve early epithelialization, thereby 
allowing earlier rehabilitation of the ocular surface by maintaining the protective and 
supportive function of the conjunctiva. This may prove to be a superior modality of 
treatment compared to conventional conjunctival autograft, particularly in diseases that 
require extensive conjunctival excision, or in the context of preserving conjunctiva for 
future glaucoma surgery. Cultivated conjunctival transplantation would also be useful for 
conjunctival replacement in eyes with conjunctival shortening or contracture resulting 
from cicatrizing diseases and may prove to be a useful in the treatment of severe ocular 

















Condition Post-operative result 
    Conjunctival 
epithelialization 
at 72 hours  
Graft 
integrity   
Resolution 
of disease  
Recurrence of 
disease 
Complications Follow-up  
1 10 / F Left  Extensive 
conjunctival nevus 
involving the inferior, 
nasal and temporal 
bulbar conjunctiva 
+ + + Minimal 
recurrence at 
the edge of the 
surgical site 
Nil 18 months 
2 42 / M Right Nasal pterygium + + + Nil Nil 
 
12 months 
3 28 / M Left Persistent leaking 
bleb with ocular 
hypotony 
+ + + Nil Nil 6 months 
4 73 / M Left  Persistent leaking 
bleb with ocular 
hypotony 













Condition Post-operative result 
    Conjunctival 
epithelialization 
at 72 hours  
Graft 
integrity   
Resolution 
of disease  
Recurrence of 
disease 
Complications Follow-up  
responded to 
topical antibiotics 
within 1 week 
5 54 / F Right Superior limbic 
keratoconjunctivitis 
+ + + Nil Nil 9 months 
 




















Pterygium is a common fibrovascular proliferative disease affecting the ocular surface, 
which may result in visual deterioration from encroachment of the visual axis,  
progressive scarring and irregular astigmatism. A wide variety of surgical methods have 
been employed in its treatment, with the aims of ensuring a good cosmetic result, 
reducing the risk of recurrence, and minimizing complications. The methods adopted 
include bare sclera excision, with or without the adjunctive use of mitomycin-C or beta-
irradiation (Cardillo et al., 1995; Lam et al., 1998; Manning et al., 1997; Chen et al., 1995; 
Aswad and Baum, 1987), or wound closure using a conjunctival autograft (Lewallen, 
1989; Mahar, 1997; Tan et al., 1997), conjunctival rotation autograft (Jap et al., 1999), 
conjunctival limbal autograft (Mutlu et al., 1999), conjunctival flap (Lei, 1996),  and 
more recently, human amniotic membrane (Prabhasawat et al., 1997). Although much of 
the previous literature has focused on the efficacy of these treatment modalities, the 
various approaches targeted at minimizing recurrence must be weighed against the risk of 
potential blinding complications of treatment (Vrabec, 1993).  
 
Wide variation exists between surgeons regarding the extent of surgical excision of the 
pterygium and subconjunctival fibrovascular tissue (Chen, 1995; Tan et al., 1997; Mar et 
al., 2000). More extensive excisions may lower recurrence rates, but require harvesting of 
larger conjunctival grafts, which are left to heal by secondary intention, resulting in 
greater postoperative inflammation, scarring and fibrosis at the superior bulbar 
conjunctival harvest site (Vrabec, 1993). Some complications related to prolonged wound 
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healing and fibrosis, such as pyogenic granuloma formation, are easily treated; others 
such as symblepheron formation, forniceal contracture, ocular motility restriction and 
diplopia, scleral necrosis and infection, are often more difficult to manage, and may be 
potentially sight-threatening (Solomon et al., 2001, Rubin feld et al., 1992, Mackenzie et 
al., 1991). Furthermore, as the superior bulbar conjunctiva is the preferred site for 
autograft harvesting, subsequent glaucoma surgery in these patients is associated with a 
high risk of failure.  
 
The use of an autologous ex vivo expanded conjunctival epithelium to replace these 
epithelial defects, allows for a more rapid rehabilitation of the ocular surface, without 
inducing iatrogenic injury associated with harvesting conjunctival autografts or flaps. 
Bioengineered conjunctival equivalents may provide a useful alternative to conjunctival 
autograft surgery, as it removes the need for harvesting large autografts and minimizes 
iatrogenic injury to the ocular surface. I performed a prospective clinical trial to evaluate 
the efficacy and safety of autologous cultivated conjunctival transplantation for the 








Forty patients with primary pterygium were enrolled in a non-randomised prospective 
clinical trial in a tertiary referral hospital from 1998 to 2002. The clinical trial protocol 
and informed consent form were approved by the Singapore Eye Research Institute 
Ethics Committee, the Singapore National Eye Centre Institutional Review Board, and 
the study conduct conformed to scientific principles embodied in the World Medical 
Association Declaration of Helsinki, as revised in 1989. Written informed consent was 
obtained from all patients. The inclusion criteria were: (1) primary pterygium scheduled 
for elective surgical excision; (2) surgical indications such as the presence of ocular 
surface symptoms in the affected eye, loss of visual acuity from visual axis obscuration,  
irregular astigmatism, or cosmesis; (3) age older than 20 years and mentally sound. 
Exclusion criteria were: (1) presence of other anterior segment disease, such as Sjogren’s 
syndrome; (2) previous ocular trauma or surgery in that eye; (3) lid margin disease or lid 
abnormalities, such as ectropion or lagophthalmos; (4) good vision in only one eye; (5) 
history of glaucoma or (6) steroid responders. The demographic data, preoperative 
examination, patient symptomatology, surgical procedure, postoperative outcome, and 
complications were recorded on an itemized data collection form.  
 
All surgical procedures were performed in a similar manner, in terms of the amount of 
pterygial and subepithelial fibrovascular tissues removed. Patients were seen on day 1 
after surgery, at 1 week, and 1, 3, 6 and 12 months. All patients had a minimum follow-
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up period of 12 months, and all had documented photographs of the preoperative and 
postoperative appearance following surgery. At each follow-up visit, visual acuity, 
tonometry, and slit-lamp examination of the graft was performed. Fluorescein staining 
was used to access the integrity of the epithelial sheet.  
 
Conjunctival recurrence was defined as the presence of fibrovascular tissue regrowing 
into the excised area that did not cross the limbus and invade the cornea. True (corneal) 
recurrence was defined as the presence of fibrovascular tissue extending beyond the 
surgical limbus onto clear cornea.  
 
Development of a conjunctival epithelial equivalent  
 
Two weeks prior to the definitive surgical procedure, a superior forniceal conjunctival 
biopsy, measuring 1mm x 2mm in size, was performed under topical anesthesia, from the 
same eye with pterygium.  The conjunctival tissue was cut into 0.5 to 1mm pieces, and 
inoculated onto the basement-membrane side of the HAM. Ex-vivo expansion of these 
conjunctival epithelial cells was carried out in serum-free medium consisting of 




All patients were anesthetized with a retrobulbar block. A 7/0 vicryl traction suture was 
placed over the superior cornea 1mm from the limbus to aid in the mobilization of the eye 
for adequate surgical exposure. The pterygium was excised in an identical manner in all 
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of the cases – the body of the pterygium was dissected 4mm from the limbus and 
reflected over the cornea. The approximate size of the conjunctival defect after 
conjunctival retraction was approximately 8mm by 8mm in all cases. Removal of the 
pterygium head was continued using a Beaver No. 64 surgical blade (Becton Dickenson, 
Waltham, MA) with careful blunt dissection.  
 
For group A patients, the cultivated conjunctival epithelial-HAM graft on the 
nitrocellulose support was positioned over the conjunctival defect and cut in size to 
extend 1mm beyond the horizontal and vertical lengths of the surgical defect. The 
conjunctival sheet was sutured in place to the underlying episclera with 8/0 virgin silk. 
An overlapping second sheet of HAM was placed basement-membrane side down over 
the entire graft to protect the epithelium from the shearing forces of blinking and sutured 
in place. A similar surgical technique was utilized for group B patients that underwent 
transplantation with denuded HAM, with the same degree of removal of pterygium tissue, 
and the same approximate conjunctival defect size of 8mm by 8mm. The appropriate size 
of denuded HAM was assessed and sutured in place in the same manner. No second 
protective sheet of HAM was required for group B patients, and HAM was left bare to 
subsequently epithelialize from the surrounding conjunctiva.   
 
The postoperative treatment regime was identical in both groups of patients. A 
subconjunctival injection of gentamicin sulfate, 10mg, and dexamethasone was 
administered at the inferior fornix at the conclusion of surgery. Postoperatively, topical 
Tobradex (tobramycin 0.3% and dexamethasone 0.1%) eyedrops (Alcon, Fort worth, 
Texas, USA) were administered every 3 hours for 1 week, 4 times daily for 2 weeks and 
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thrice daily for 2 weeks following surgery. For group A patients, the protective amniotic 
membrane was removed on the third postoperative day. Histological analysis of the 




Kaplan-Meier survival analysis was used to compare the time to true recurrence for group 
A patients undergoing cultivated conjunctival transplantation and group B patients 
undergoing transplantation of denuded HAM. The influence of age and gender on the 
relation with time to recurrence was evaluated using the non-parametric Log-rank test. 
All analyses were conducted using SPSS (version 9.0, SPSS Inc., Chicago, IL) for 








Twenty-two patients underwent pterygium excision and transplantation of an autologous 
cultivated conjunctival equivalent (group A). Patients in group A had a mean age of 
52.2+11.1 years (Table 10.1). There were 13 males and 9 females. Twenty-one eyes had 
nasal pterygium and one had a double-headed pterygium.  
 
Eighteen patients underwent pterygium excision and transplantation of denuded amniotic 
membrane (group B). Two patients in group B had less than 9 months of follow-up and 
were excluded from the analysis. Group B patients had a mean age of 60.1+8.7 years. 
There were 10 males and 6 females. Fifteen eyes had nasal pterygium and one had a 
double-headed pterygium. The mean follow-up period for all patients was 14.1+3.9 
months (range, 12 to 25 months). 
 
 
Cultivated conjunctival epithelial equivalent 
 
Initial migration of conjunctival epithelial cells from the explants onto the HAM was 
observed on day 2 of culture. The migrating cells formed an advancing epithelial sheet 
packed with round or ovoid cells. The trailing region behind the advancing edge 
demonstrated a healthy cobblestone morphology. The more central region became 
multilayered by day 5, and this continued to expand towards the periphery.  The 
confluent sheet of stratified epithelial cells was obtained over the 30mm x 30mm HAM 






Group A – Transplantation of cultivated conjunctival epithelium.  
 
Fluorescein staining immediately after removal of the HAM patch at 72 hours after 
surgery confirmed that approximately ninety percent of the underlying cultured 
conjunctival equivalent was nonstaining in all cases, confirming that the cultured 
epithelial layer had remained largely intact. At 5 days, repeat staining with fluorescein 
confirmed that complete epithelialization was present in all eyes. None of the 
transplanted amniotic membranes sloughed off and there was no case of late epithelial 
breakdown. No significant scarring was noted directly over or adjacent to the surgical site. 
In all cases, there was less conjunctival inflammation, as compared to what would be 
expected for conventional conjunctival autograft surgery, with no cases of chemosis 
noted. The ocular surface of eyes with surviving transplanted epithelium remained stable 
and healthy. Five eyes (22.7%) developed fibrovascular recurrence extending beyond the 
limbus (true corneal recurrence), while an additional 2 eyes (9.1%) developed 
conjunctival recurrence without encroachment into the limbus. The time to true 
recurrence was 4.8+1.6 months. In 3 of the 5 eyes that had true recurrence, the recurrent 
tissue was limited to within 0.5 mm from the limbus, which was a marked improvement 





Group B – Transplantation of denuded HAM.  
 
At 72 hours, all eyes were largely non-epithelialized. Complete epithelialization was only 
achieved in approximately 3 weeks. None of the membranes sloughed off. No significant 
scarring was noted over the surgical site. Four eyes developed a true recurrence (25.0%), 
while conjunctival recurrence not encroaching the limbus occurred in 5 eyes (31.0%).  
The time to true recurrence was 5.0+2.9 months. 
 
Log-rank analysis of the various factors, such as age and gender, showed that these were 




Table 10.1. Data of patients that underwent cultivated conjunctival transplantation and 
denuded HAM transplantation 
 
 
 Cultivated conjunctival 
transplants (Group A) 
Denuded HAM 
transplants (Group B) 
No. of eyes 22 16 
OD 11 9 
OS 11 7 
Location  21 nasal 
1 double-headed pterygium 
15 nasal 
1 double-headed pterygium 
Gender 13 males / 9 females 10 males / 6 females 





epithelialization at 72 hours 
22/22 (100%) 0/16 (0%) 
Symblepharon formation 0/22 (0%) 0/16 (0%) 
True corneal recurrence 5/22 (22.7%) 4/16 (25.0%) 
Conjunctival recurrence 2/22 (9.1%) 5/16 (31.0%) 
Time to true recurrence 4.8+1.6 months 5.0+2.9 months 
Complications Nil 1 scleral melt and persistent 
epithelial defect (6.0%) 
Follow-up (months), 
mean+SD (range) 
12.9+2.8 months (12 to 25 
months 







Kaplan-Meier survival analysis (Fig. 10.1) was performed for group A and B patients 
(survival being defined as the absence of true recurrence). In group A patients that 
underwent cultivated conjunctival transplantation, the cumulative proportion of patients 
without true recurrence at 5 and 10 months were 0.909+0.091 and 0.773+0.089 
respectively. These results were fairly similar to group B patients that underwent denuded 
HAM transplantation, where the cumulative proportion of patients without true 




There were no significant complications in group A patients that underwent cultured 
conjunctival transplantation. None of the eyes developed symblepharon or ocular motility 
restriction.  
 
In group B patients, 1 eye (6.0%) developed scleral necrosis with a persistent 
conjunctival epithelial defect within 2 months after surgery. The depth of scleral melt was 
estimated to be approximately 50%, and the patient was treated with ocular lubricants and 
topical antibiotic prophylaxis. No further melting occurred and the overlying epithelial 
defect eventually healed after 3 months.  
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Figure 10.1. Kaplan-Meier survival analysis of true recurrence after pterygium excision 
in patients undergoing cultivated conjunctiva-HAM transplantation and patients 
undergoing simple denuded HAM transplantation. Continuous line: cultivated 










Case 2:  
A 52-year-old man presented with irritation, intermittent redness, and increasing growth 
of a nasal primary pterygium encroaching the visual axis in his left eye for several years 
(Fig. 10.2A).  The pterygium was excised and the cultivated conjunctival epithelial sheet 
was transplanted over the surgical defect which measured approximately 10mm vertically 
x 8mm horizontally. Complete epithelialization was noted within 72 hours.  The degree 
of inflammation was noted to be relatively mild, with no evidence of conjunctival or graft 
chemosis. There was no recurrence of the pterygium noted at the last follow-up visit at 17 
months (Fig. 10.2B).    
 
Case 8.  
A 54-year-old woman with a double-headed pterygium in the right eye for several years, 
complained of ocular irritation and increasing size of the pterygium (Fig. 10.3A). Both 
heads of the pterygium were excised and 2 cultivated conjunctival epithelial sheets were 
transplanted over the nasal and temporal surgical defects. Complete epithelialization was 
noted within 72 hours.  A good postoperative result was noted within 2 months of surgery 
(Fig. 10.3B). However, in the third month, pterygium recurrence was developed in the 
nasal region (Fig. 10.3C). This patient subsequently underwent a conventional 
conjunctival autograft surgery for the nasal recurrence, and remained recurrence-free at 




Figure 10.2. Case 2. (A), the preoperative external photograph showing a nasal primary 
pterygium encroaching the visual axis in the left eye. (B), 17-month postoperative 







Figure 10.3. Case 8. (A), the 
preoperative external photograph 
showing a double-headed pterygium in 
the right eye. (B), 2-month postoperative 
appearance showing a good cosmetic 
result, with minimal scarring and 
absence of recurrence. (C), 6-month 
postoperative appearance showing the 
presence of a nasal recurrence of the 
pterygium invading the cornea. The 
temporal aspect remained recurrence-







The use of autologous cultivated conjunctival epithelial sheets represents a novel method 
of conjunctival epithelial transplantation and replacement for a wide variety of 
conjunctival diseases. The advantage of this procedure is the almost immediate 
epithelialization of the ocular surface following removal of large areas of diseased 
conjunctiva. Pterygium, a common ocular surface disorder, was treated with autologous 
cultivated conjunctival epithelial equivalents. Epithelial coverage was achieved at a much 
earlier rate compared to conventional transplantation using denuded amniotic membranes, 
thereby allowing earlier rehabilitation of the ocular surface, reducing the degree of 
postoperative inflammation, and maintaining the protective and supportive functions of 
the conjunctiva. In addition, the presence of early epithelialization may help to reduce the 
risk of potentially sight-threatening conditions, such as scleral necrosis, perforation or 
infection.  
 
The two most critical issues in pterygium surgery are reducing pterygium recurrence, and 
minimizing complications arising from treatment. The considerations for pterygium 
surgery are the extent of removal of the pterygium and subepithelial fibrovascular tissue, 
the use of adjunctive measures, and the management of the conjunctival defect. The 
various modalities employed in the treatment of pterygium have focused primarily on 
reducing recurrence. Intraoperative mitomycin-C and beta-irradiation, have reduced 
recurrence rates associated with pterygium excision, but have also been associated with 
serious sight-threatening complications (Tarr and Constable, 1980; Mackenzie et al., 
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1991; Rubinfeld  et al., 1992; Dougherty et al., 1996). Conjunctival autografting is safe 
and effective, but the procedure is more time-consuming and technically demanding to 
perform, and wide variation in recurrence rates exist owing to differences in surgical 
technique and surgeon experience (Lewallen, 1989; Chen et al., 1995; Tan et al., 1997; 
Mutlu et al., 1999). The extent of surgical removal varies between reports, from localized 
excisions several millimeters from the limbus, to extensive wide field excisions 
(Lewallen, 1989; Prabhasawat et al., 1997; Ma et al., 2000). More extensive excision 
reduces the amount of residual disease tissue, but this necessitates harvesting a larger 
conjunctival autograft, resulting in greater iatrogenic injury to the donor site. Harvesting 
a superior bulbar conjunctival graft results in injury and scarring at the harvest site 
(Vrabec et al., 1993), which further complicates the management of patients with 
associated ocular surface disease or glaucoma, particularly if glaucoma filtration surgery 
is contemplated.  
 
The use of denuded HAM in pterygium surgery requires that healing has to occur by 
secondary intention, with gradual epithelial migration from the adjacent conjunctiva. 
Complete epithelialization has been described to take up to 3 weeks to occur 
(Prabhasawat et al., 1997). Delayed epithelialization may be associated with more 
prolonged ocular surface inflammation and the risk of membrane melting or infection, as 
demonstrated in our patient that underwent denuded amniotic membrane transplantation. 
Previous studies on amniotic membrane grafts managed to achieve recurrence rates of 3 
to 10.9% by extensive excision of the pterygium and subconjunctival tissue up to the 
superior and inferior fornices and nasal caruncle, sometimes sacrificing the semilunar 
  
127 
fold (Prabhasawat et al., 1997; Solomon et al., 2001; Ma et al., 2000). These studies 
reported a 6.1% risk of symblepharon formation following these large surgical excisions 
(Solomon et al., 2001). We were more conservative with regards to the extent of excision 
of the pterygium and subconjunctival fibrovascular tissue compared to previous reports 
(Prabhasawat et al., 1997; Solomon et al., 2001). Autologous cultivated conjunctival 
transplantation resulted in complete epithelialization within 3 to 5 days, with a more rapid 
healing and resolution of inflammation compared to denuded HAM transplantation. The 
recovery was also faster than what would have been expected with conventional autograft 
surgery. True corneal and conjunctival recurrence rates for the cultivated conjunctival 
transplantation were lower than that of denuded HAM transplantation. In addition, there 
was minimal subepithelial fibrosis and scarring, and none of the eyes developed 




and beta irradiation have helped to reduce recurrence rates, they 
have been associated with potentially serious complications, such as scleral necrosis, 
infectious scleritis, secondary glaucoma, iritis, corneal edema and corneal perforation 
(Tarr and Constable, 1980; Mackenzie et al., 1991; Rubinfeld  et al., 1992; Dougherty et 
al., 1996). These complications have been reported in up to 13% of patients, with latency 
periods of up to 19 years, suggesting that patients may have a lifelong risk of potentially 
blinding complications. Scleral necrosis has also been reported in bare sclera excision or 
retracted conjunctival autografts (Alsagoff et al., 2000; Ti and Tan, 2003). The 
predisposing factors for this complication are the lack of epithelial covering, the more 
prolonged recovery and the greater degree of inflammation in these patients. An intact 
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epithelium has been shown to effectively prevent microbial or non-microbial ulceration 
(Wagoner and Kenyon, 1987; Kenyon, 1982). This was supported by experimental 
studies that showed that an intact epithelium was critical in preventing sterile ulceration, 
by inhibiting collagenase production (Johnson-Wint and Gross, 1984). None of the 
patients undergoing cultured conjunctival transplantation developed scleral melting, 
compared to 6.0% in the denuded HAM group. Because early epithelialization is an 
important factor in preventing scleral necrosis, transplantation of cultured conjunctival 
epithelium is useful in maintaining epithelial integrity and may help to minimize such 
complications.  
 
The present study has several limitations. It was non-randomized and the study 
population was small. However, the findings of our study suggest that transplantation of 
autologous cultured conjunctiva is a viable procedure with demonstrable survival of the 
cultured conjunctival epithelium in at least the short-term. As such, the advantages of 
autologous cultivated conjunctival transplantation include facilitating early 
epithelialization, faster resolution of inflammation and faster postoperative recovery. It 
may also aid in preventing complications associated with delayed epithelialization, such 
as scleral necrosis and secondary infection, and removes the need for harvesting large 
conjunctival autografts which would complicate future glaucoma filtration surgery. The 
more rapid recovery may help reduce scarring and symblepharon formation arising from 
chronic defects of the ocular surface. The use of an autologous cultivated conjunctival 
epithelial equivalent may be particularly useful for the treatment of various ocular surface 
disorders, such as diseases requiring wide-field excision of the conjunctiva, severe ocular 
  
129 
surface diseases that destroy the conjunctiva, such as Stevens-Johnson syndrome and 
chemical burns, or in situations where the conjunctiva needs to be preserved for future 
























Serum-free media has primarily been for the study of factors that modulate cellular 
proliferation and differentiation (Kruse and Tseng, 1991a; 1991b; Castro-Munozledo et 
al., 1997; Tsao et al., 1982; Lechner, 1984; Shipley and Pittelkow, 1987; Hackworth et 
al., 1990). Serum-free media has not been used in the ex vivo expansion of ocular surface 
cells for clinical transplantation. This may be attributed to the lack of information 
regarding the efficacy of serum-free media in supporting the serial propagation of cells 
compared to serum-containing methods, as well as the uncertainty of the viability and 
proliferative potential of these cells when transplanted back to the in vivo environment.  
 
I demonstrated that a chemically defined serum-free culture system supports the clonal 
growth, serial propagation and differentiation of human conjunctival epithelial cells. The 
elimination of serum and feeder cells from the culture system has many advantages. It 
provides a more defined condition for future investigations on the effect that different 
cytokines have on the growth and proliferation of conjunctival epithelial cells. It also 
reduces the risk of transmission of zoonotic infection when used in the ex-vivo expansion 
of cells for clinical transplantation.  
 
Serum-free cultivated cells retained their innate ability to form a stratified epithelium 
when returned to the in vivo environment, as demonstrated by the aggregation and 
organization of injected cells to form cysts that were lined by stratified squamous 
epithelium. Cysts derived from cells cultured in serum-free media and serum-containing 
media with feeder cells were similar in terms of morphology as well as degree of 
stratification. The number of cells present in the cysts derived from serum-free cultures 
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and those derived from serum-containing media and 3T3 cultures were almost identical, 
demonstrating that the elimination of serum from the culture process did not compromise 
the in vivo growth response of these conjunctival epithelial cells. Because the in vivo 
proliferation of cells derived from serum-free cultures was comparable to those from 
serum and 3T3 cultures, this supports its use in the ex vivo expansion of epithelial cells 
and the development of ocular surface equivalents for clinical transplantation, without the 
attendant disadvantages associated with the use of bovine serum and animal feeder cells. 
 
I described the effective use of a serum-free culture system for the development of a 
transplantable human conjunctival epithelial sheet on amniotic membrane. In addition, I 
showed that conjunctival epithelial cells cultured in a low-calcium serum-free culture 
system had a greater proliferative capacity than cells cultivated in conventional serum-
containing media, which is particularly important when considering propagating these 
cells for clinical transplantation. 
 
Previous studies on ocular surface equivalents have relied primarily on serum-
supplemented media for the cultivation of epithelial cells. These studies focused mainly 
on the formation of a differentiated epithelial equivalent bearing the morphological 
characteristics of the original tissue (Schwab et al., 2000; Tsai et al., 2000; Grueterich 
and Tseng, 2002; Meller, Pires and Tseng, 2002; Tsai and Tseng, 1988; Niiya et al., 1997; 
Meller and Tseng, 1999; Meller et al., 2002). These terminally differentiated cells 
contribute to the structural and functional attributes of the tissue, but have a limited 
proliferative capacity in the long-term. The ability of the cultivated cells to remain 
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proliferative in vivo is important for the long-term regeneration of the tissue following 
transplantation. I demonstrated the use of a multistep serum-free culture system in 
developing a conjunctival epithelial equivalent with improved proliferative and structural 
characteristics, which are crucial for the regeneration of the conjunctival surface 
following clinical transplantation.   
 
The use of tissue-equivalents in ocular transplantation requires that cells are sufficiently 
attached to the underlying substrate, to prevent them from being sloughed off during or 
following surgery, and from blinking or saccadic movements of the eye. By altering the 
calcium concentration of the culture medium in our multistep approach, thereby making 
use of the growth modulating effect of this exogenous factor, submerged cultures 
elaborated a continuous basement membrane with numerous hemidesmosomes, as well as 
numerous intercellular desmosomes. In addition, the conjunctival epithelial equivalent 
expressed the differentiation-related markers that are consistent with that of normal 
conjunctiva.  
 
The use of autologous cultivated conjunctival epithelial sheets represents a novel method 
of conjunctival epithelial transplantation and replacement for a wide variety of 
conjunctival diseases. The advantage of this procedure is the almost immediate 
epithelialization of the ocular surface following removal of large areas of diseased 
conjunctiva. The elimination of bovine serum and murine feeder cells from the culture 
system has the advantage that it reduces the risk of transmission of zoonotic infection and 




The advantages of autologous cultivated conjunctival transplantation include facilitating 
early epithelialization, faster resolution of inflammation and faster postoperative recovery. 
It may also aid in preventing complications associated with delayed epithelialization, 
such as scleral necrosis and secondary infection, and removes the need for harvesting 
large conjunctival autografts which would complicate future glaucoma filtration surgery. 
The more rapid recovery may help reduce scarring and symblepharon formation arising 
from chronic defects of the ocular surface.  
 
The use of an autologous cultivated conjunctival epithelial equivalent may be particularly 
useful for the treatment of various ocular surface disorders, such as diseases requiring 
wide-field excision of the conjunctiva, severe ocular surface diseases that destroy the 
conjunctiva, such as Stevens-Johnson syndrome and chemical burns, or in situations 



















The use of bioengineered conjunctival equivalents represents a novel approach to replace 
diseased conjunctiva with healthy epithelium, without causing iatrogenic injury from 
harvesting large autografts. It is particularly useful in situations where the normal 
conjunctiva is deficient either from disease or scarring. Current methods used to 
bioengineer tissue-equivalents utilize serum-containing culture media and murine 3T3 
feeder cells, with the attendant disadvantages of the variability of serum that varies from 
batch to batch, and the risk of transmission of zoonotic infection or xenograft rejection.   
 
I have developed a serum-free culture system for the in vitro propagation of conjunctival 
epithelial cells, which remained proliferative in vivo and maintained the normal in vivo 
characteristics of the original tissue. These findings suggest that serum-free cultures may 
be an effective alternative to serum-containing cultures for the propagation of 
conjunctival epithelial cells. This is particularly important in situations where the 
elimination of animal serum and tissue is advantageous, such as in the study of various 
factors involved in modulating cell proliferation and differentiation, as well as in the area 
of bioengineering for clinical transplantation, where the use of a serum-free culture 
system is an important step towards reducing the risk of transmission of infection and 
xenograft rejection. 
 
I have described the development of a conjunctival epithelial equivalent, using a 
multistep serum-free culture system to enhance cell proliferation, differentiation and 
attachment for clinical transplantation and tissue regeneration. These cultivated 
conjunctival epithelial equivalents were successfully used for the treatment of patients 
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with ocular surface disorders that required conjunctival excision and replacement. The 
elimination of serum and feeder cells is a significant and important improvement over 
existing serum-containing methods of cultivating cells for clinical transplantation. These 
findings have important clinical implications and are important for the development of a 
safe and effective bioengineered tissue-equivalent for clinical use, such as in the 
regeneration of the ocular surface in conditions where the normal conjunctiva is damaged 
or deficient. 
 
The benefits of transplantation of autologous conjunctival epithelial equivalents include 
the ability to immediately resurface the globe and achieve early epithelialization, thereby 
allowing earlier rehabilitation of the ocular surface by maintaining the protective and 
supportive function of the conjunctiva. This may prove to be a superior modality of 
treatment compared to conventional conjunctival autograft, particularly in diseases that 
require extensive conjunctival excision, or in the context of preserving conjunctiva for 
future glaucoma surgery. Cultivated conjunctival transplantation would also be useful for 
conjunctival replacement in eyes with conjunctival shortening or contracture resulting 
from cicatrizing diseases and may prove to be a useful alternative in the treatment of 
severe ocular surface disorders that invariably involve the conjunctiva. Further studies 
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Appendix I  Serum-free media for cell culture 
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SERUM-FREE CULTURE MEDIA 
 
Keratinocyte Growth Medium (Biowhittaker, Walkersville, MD, USA) supplemented 
with : 
 
• 10ng/ml human epidermal growth factor  
• 5µg/ml insulin  
• 0.5µg/ml hydrocortisone  
• 30µg/ml bovine pituitary extract  
• 50µg/ml Gentamicin  




             
 
SERUM-CONTAINING CULTURE MEDIA 
 
1:1 DMEM-Ham’s/F12 nutrient mixture, supplemented with: 
 
• 10% FBS 
• 5µg/ml insulin 
• 0.5µg/ml hydrocortisone 
• 8.4ng/ml cholera toxin 
• 24µg/ml Adenine 
• 100IU/ml penicillin 





REAGANTS AND SUPPLEMENTS  
 
 
Hydrocortisone  (Sigma H0888)  MW 362.5 
Stock solution is 5x10-3M  (=10,000x).  Final concentration in medium is 5x10-7M. 
Weigh 18mg hydrocortisone and add 10ml 95% EtOH. 
Store at -20oC.   
 
Epidermal Growth Factor: 
 (Gibco #13247-051 recombinant human). 
Stock solution is 10µg/ml  (=1000x).  Final concentration in medium is 10µg/liter 
(=10ng/ml). 
To a vial containing 100µg, add 10ml sterile deionized H2O.   
 
Cholera Enterotoxin: 
Company: Sigma;  Cat.#: C8052;  Lot #: 24H4052 
Dissolve 1mg cholera toxin in 1.2ml sterile water to give 0.833 mg/ml = 833 µg/ml. 
 
Take 0.1ml of this and add to 100ml Earles salt + 0.1% BSA + 25mM Hepes  
to make a 0.833 µg/ml stock (100x). 
 
To get final concentration of 8.33 ng/ml in the medium:  




Insulin  (from bovine pancreas, Sigma I6634). 
Stock solution is 5mg/ml  (=1000x).  Final concentration in medium is 5mg/liter. 
Weigh 50mg insulin and add 10ml of 0.01M HCl  (For Baker #9535-3, 11.6N, use 86.2 
µl conc. HCl diluted in 100ml H2O; for Fisher #A-144, 12.1N, use 82.6 µl conc. HCl 
diluted in 100ml H2O).   
Vortex to dissolve. 
Sterile filter through 0.22µ Millex GV syringe filter (Millipore). 
Store in 1ml aliquots at -20oC. 
 
Adenine: 
Company: Sigma; Cat #: A9795;  Lot #: 31H06015 
Weigh 242mg of adenine and add 100ml sterile 0.05N HCl to make a 2.42 mg/ml stock 
(100x). 
Stir for ≈1hr at RT.  Filter-sterilize.  Store in 10ml aliquots at -20
0
C. 
To get a final concentration of 24 µg/ml in the medium: 
for 400ml of medium, add 4ml of 2.42 mg/ml stock.   
 
Ethanolamine  (Sigma E9508). 
Stock solution is 0.1M (=1000x).  Final concentration in medium is 0.1mM. 
Take 59.9µl ethanolamine and bring to 10 ml with deionized H2O. 
Sterile filter through 0.22µ Millex GV syringe filter (Millipore). 




O-Phosphoethanolamine  (Sigma P0503)  MW 141.1 
Stock solution is 0.1M (=1000x).  Final concentration in medium is 0.1mM. 
Weigh 0.141g phosphoethanolamine and add 10ml deionized H2O. 
Sterile filter through 0.22µ Millex GV syringe filter (Millipore). 
Store in 1ml aliquots at -20oC. 
 
Penn/Strep   
Stock solution is 10,000IU/ml and 10,000mcg/ml respectively (=100x). 







LIST OF MATERIALS AND SUPPLIERS 
 
 
CULTURE MEDIA AND SOLUTIONS 
 
 
ITEM  SUPPLIER 
Dulbecco’s modified Eagles’s medium   Gibco (Grand Island, NY, USA) 
Hank’s balanced  salt solution  Gibco  
Human epidermal growth factor   Gibco  
Penicillin  Gibco  
Streptomycin  Gibco  
Amphotericin B  Gibco  
Insulin  Sigma (St. Louis, MO, USA) 
Hydrocortisone  Sigma  
Bovine pituitary extract  Sigma  
Cholera toxin  Sigma  
Adenine  Sigma  
Keratinocyte growth medium  Biowhittaker  (Walkersville, MD, USA) 
Fetal bovine serum (FBS)  Hyclone (Logan, Utah, USA) 





CHEMICALS AND MATERIALS  
 
 
ITEM  SUPPLIER 
Mitomycin C  Sigma  
Dimethyl sulfoxide  Sigma  
Dispase II  Gibco  
Trypsin  Gibco  
Ethylenediaminetetraacetic acid   Gibco  
Nitrocellulose filter paper   Millipore ( Bedford, MA, USA) 
Tissue culture plastic plates  Corning (Corning, NY, USA) 
BrdU labeling solution   Amersham Biosciences (Freiburg, 
Germany) 
   
   
   
   
   
   
   
   
   





             




MATERIAL  SUPPLIER 
Vectastain Peroxidase Kit   Vectastain Elite Kit (Vector Labs, 
Burlingame, CA, USA) 
Diaminobenzidinetetrahydrochloride 
Substrate  
 Sigma  
Fluorescein Isothiocyanate Labeled 
Goat Anti-Mouse Igg 
 Chemicon (Temecula, CA, USA) 
Propidium Iodide   Chemicon (Temecula, CA) 
Tissue-Tek OCT Freezing Compound  Sakura Finetek (Torrance, CA) 










Normal Mouse Monoclonal IgG Antibody  Sigma  
Cytokeratin 4 Antibody  Sigma  
Cytokertin 12 Antibody   Santa Cruz Biotechnology (CA) 
Cytokeratin 19 Antibody  DakoCytomation (Carpinteria, CA) 
Cytokeratin 3 (AE-5) Antibody    A kind gift from T. T. Sun from New 
York University 
Pancytokeratin (AE-1 And AE-3) Antibody  Sigma  
MUC5AC Antibody  Chemicon (Temecula, CA, USA) 
Biotinylated Horse Anti-Mouse 
Immunoglobulin G 
 Vectastain Elite Kit (Vector Labs, 
Burlingame, CA, USA) 
 
